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ABSTRACT 
A high performance liquid chromatography (HPLC) assay has been developed 
and validated for the antifoarn agent Simethicone (polydimethylsiloxane + silicon 
dioxide) as used in antacid formulations. The method relies on a reversed-phase 
gradient HPLC system with the key component being the use of an evaporative 
light scattering detector (ELSD). The ELSD is a universal detector with particular 
application to eluants which have no UV chromophore. Separation of 
Simethicone was achieved using a reversed-phase column (C8) and elution with 
an acetonitrile- chloroform gradient. A low molecular weight 
polydimethylsiloxane (MW 1800) can be resolved completely into its oligomers 
by the appropriate solvent gradient, whereas a higher molecular weight 
polydimethylsiloxane (MW 27,000) is resolved to a limited extent only. The 
Simethicone content in a commercial antacid emulsion formulation was 
quantitatively determined, and the validated method used to assay samples of the 
formulation in stability trials. 
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Chapter 1 Introduction 
Chapter 1: Introduction 
1.1 Polydimethylsiloxane 
A polymer is a large molecule built up by the repetition of a simple chemical unit, or 
monomer. In some cases the repetition is linear, much as a chain built up from its links, 
but in other cases, the chains are branched or interconnected to form three-dimensional 
networks (Urbanski et al, 1977). Commercial polysiloxanes, commonly referred to as 
silicone oils, are the product of hydrolytic polycondensation of the monomers, which are 
low molecular weight organosilicon compounds polydimethylsiloxane (PDMS) is an 
example of the polysiloxanes, having the Chemical Abstract name of a-(trimethylsilyl)-
ro-methylpoly[oxy(dimethylsilylene] and CA registry Number [8050-81-5]. The main 
trivial name for PDMS is dimethicone, although the European and British 
Pharmacopoeias refer to it as Dimeticone (USP, 2000). There are also a number of more 
or less proper synonyms and commercial names used for this polymer, such as 
Dimethylsiloxane, Methyl-polysiloxane, Polymethylsiloxane, Permethylpolysiloxane and 
Antifoam A or MS, (BP, 2000). In this thesis, the name polydimethylsiloxane and 
acronym PDMS will be used. The chemical structure ofPDMS is: 
CH3 CH3 CH3 
I I I 
CH3-Si-O Si-0 Si-CH3 
I I I 
CH3 CH3 CH3 
n 
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where n is the degree of polymerization or chain length, normally having a value between 
150 and 400. PDMS is synthesized by hydrolysis and polycondensation of 
dichlorodimethylsilane with chlorotrimethylsilane. Any individual preparation of PDMS is 
a mixture of polymeric molecules, i.e. , it contains a distribution of chain lengths centered 
about the average degree of polymerization. Various different preparations are therefore 
available, depending upon the average chain length. The characterizing physical property 
of each silicone oil is its vi~cosity. The different dimethicones are therefore distinguished 
by a number after the name indicating the declared viscosity which, in terms of kinematics 
viscosity, is between 20 and 1300 mm2 s-1 (BP, 2000). PDMS is a clear colorless liquid, 
insoluble in water, but miscible with many organic solvents. It has a number of 
applications in food processing, cosmetics and pharmaceuticals as an antifoaming and 
lubricating agent, resulting from its water repellent and surface tension lowering effects 
(Luck, 1997). 
1.2 Simethicone and Simethicone Emulsion 
Simethicone is defined by the United States Pharmacopoeia as a mixture of fully 
methylated linear silicone polymers containing repeating units of the formula (-
(CH3)2Si0-), stabilized with trimethylsiloxyl end-blocking units of formula ( -(CH3)2SiO-), 
and finely divided silicon dioxide. In other words, it is PDMS with particulate Si02 added 
to enhance the defoaming properties of the silicone. The degree of polymerization n has an 
average value such that the corresponding nominal viscosity is in a discrete range between 
20 and 30,000 centistokes (USP24/NF19, 2000). 
Simethicone is a milky-white paste with essentially no characteristic odor, it is a viscous, 
oil-like liquid with a density range of 0.965 to 0.970, and the viscosity at 25°C is about 
60,000 centistokes (cs). It is immiscible with water and alcohol, but miscible with 
chloroform and ether. It has no UV chromophore and contains many individual oligomers 
2 
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with different chain length. The molecular weight of the PDMS in Simethicone is 
approximately 15,000 to 27,000 (Merck, I 996). Simethicone Emulsion is a water-
dispersible form of Simethicone with the addition of suitable emulsifiers, preservatives, 
and water. It may contain suitable viscosity-increasing agents (USP24/NF19, 2000). 
Simethicone 30% emulsion is a preparation for pharmaceutical use and contains between 
27.80 to 31.60 percent of polydimethylsiloxane. 
The BP does not contain a monograph of Simethicone, but its dimeticone monograph 
defines dimeticone as a polydimethylsiloxane obtained by hydrolysis and 
polycondensation of dichlorodimethylsiloxane and chlorotrimethylsilane. Different grades 
exist, distinguished by a number indicating the nominal viscosity placed after the name. 
Their degree of polymerization (n = 20 to 400) is such that their kinematic viscosities are 
nominally between 20 cs and 1300 cs. Each is a clear, colorless liquid of designated 
viscosity, insoluble in water, very slightly soluble to practically insoluble in ethanol, but 
miscible with ethyl acetate, methyl ethyl ketone and toluene (BP, 2000). 
1.3 Applications of Simethicone 
1.3.1 General uses 
Simethicone is a common ingredient in cosmetics and hair-care products, where it serves 
as a spreading agent and moisture retainer, adding lustre and sheen. It is claimed to allow 
cleaning and conditioning in one step (Rushton et al, 1994 ), overcoming problems with 
anionic surfactants and cationic conditioners that result in charge interaction and 
complexing of the ingredients (Heidenkumer and Kampik, 1991 ). 
In food processing, Simethicone is used as a defoaming agent (Gooch, 1993). Its effect 
on foaming systems containing synthetic gastric juice and a surface active substances 
(anionic surfactant, cationic surfactant, soap solution) was quantified by measuring the 
3 
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surface tension, foam stability and initial foam density (Bergeron et al, 1997). The effect 
of Simethicone was the result of combination of two actions: the drainage of liquid from 
foam films and the rupture of relatively thick liquid films. The mechanism of these 
actions may be described as liquid drainage followed by bridging of the liquid film by 
PDMS droplets, helped by hydrophobic silica particles also present in the antifoam agent, 
leading to the rupture of the film surface and air escape (Brecevic et al, 1994). 
1.3.2 Pharmaceutical uses 
The principal application of Simethicone in a pharmaceutical sense is for the alleviation of 
intestinal gas, a cause of significant discomfort to many people (Ali et al, 1998). 
Simethicone is therefore a common additive to antacid formulations. Its efficacy was 
assessed by comparing the effect of a Simethicone-containing antacid gel with a simple 
antacid gel in a double blind trial in 45 patients with reflux oesophagitis. The results 
suggested that a Simethicone-containing antacid is of value in the treatment of 
symptomatic gastro-oesophageal reflux. Intestinal gas is also the most common cause of 
technically unsatisfactory abdominal ultrasound scans. In an attempt to improve the 
visualization of abdominal organs, many investigators use anti foaming agents or laxatives 
(Olivie and Atkinson, 1996). Examples of antacid-containing preparations designed to 
provide relief from indigestion, upset stomach, heartburn and wind pain, include liquid 
and tablet formulations. A typical liquid formulation (Mylanta Antacid Liquid-
manufactured by Pfizer-Warner-Lambert Consumer Pty Ltd) contains magnesium 
hydroxide (400 mg/10 mL), aluminium hydroxide (400 mg/10 mL) and Simethicone (40 
mg/10 mL) with the necessary preservatives and flavors. A tablet formulation of Mylanta 
is constituted as follows: aluminum hydroxide-dried (equivalent to 50% aluminum oxide, 
anhydrous, 200 mg/tablet), magnesium hydroxide (200 mg/tablet) and Simethicone (20 
mg/tablet) with preservatives and flavours. 
Simethicone is regarded as an active component whose purpose is to act as an antifoam 
agent to disperse any accumulated gas that often causes indigestion and stomach pains. 
4 
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When taken orally it causes small bubbles of gas in the gastrointestinal tract to coalesce, 
thereby aiding their dispersion. Simethicone is taken in doses of 20 - 40 mg three or four 
times daily, as required. 
1.4 Degradation of Polymers 
The current project is concerned with the use of polymeric material in pharmaceutical 
formulations. The product development process must include stability trials for shelf-life 
determination of the product. Thus, it is important to have an understanding of the nature 
of possible breakdown processes that may affect PDMS. 
Organic polymers when first introduced were thought to be relatively indestructible. In 
fact many are regarded now as constituting an environmental problem because of their 
resistance to biodegradation. Thus a very considerable research effort is directed toward 
understanding the degradation of polymers (Leung et al, 1989). Additionally, the use of 
polymeric materials in increasingly demanding applications in recent years has also 
contributed to the demand for knowledge of polymer stability (Grassie, 1978). Polymer 
behavior and performance, particularly the durability of the polymeric material during 
manufacture and in service are generally the concern of industry laboratories (Jellinek, 
1983). 
A study of the effect oftemperature on the process of polymerization has shown that it is in 
some case reversible, so that above a so-called "ceiling" temperature, reversal of reaction 
may occur to give greater amounts of the original monomer rather than polymer. On the 
other hand, degradation of polymers leads to lower molecular weight products which are 
quite different from the starting monomer (Zhu, 1997). 
Polymers can be broken down by a variety of environmental agents. The term "polymer 
degradation" is used to denote changes in physical properties of the polymer caused by 
5 
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chemical reactions involving bond scission in the backbone of the macromolecule. In 
linear polymers, these chemical reactions lead to a reduction in molecular weight, i.e., to a 
diminution of chain length or degree of polymerization (West and Hench, 1994 ). 
Thermal degradation refers to the situation where the polymer, at elevated temperatures, 
undergoes chemical changes without the simultaneous involvement of another agent. The 
chemical change occurring during thermal treatment of polymers can be characterized by 
the following phenomena: 
•!• Chemical bonds in the main chains and/or in the side chains are ruptured, as evidenced 
by a diminution of the molecular weight of the polymer, and the evolution of low 
molecular weight gaseous products, respectively. 
•!• Intramolecular reactions such as cyclization and elimination may occur. 
•:• In the case of linear polymers, intermolecular cross-linking can occur indicated by an 
augmentation of the molecular weight (Fig 1.1 ). 
R R R R 
VJvVv 
m 
R R R R R ~ R R R R R 
Figure 1.1 Depiction of cross-linking during Thermal Degradation 
All of those processes are believed to occur via the adventitious formation of free radicals 
in the polymer molecule as a result of thermal activation. Degradation due to 
photochemical or high-energy radiation foJiows similar initiation steps. 
6 
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Mechanical degradation of polymers is observed when structural changes occur due to 
various kinds of mechanical operations (milling, shear stress, tensile forces, compression, 
ultrasonic radiation, etc). It is relevant to a manufacturing process involving polymeric 
components, where the modifying (filling, pumping) stages may cause polymer 
degradation. In all these cases chemical bonds in the polymer chain can be ruptured 
(Basedow and Ebert, 1977): 
Types of mechanical degradation in solution include: 
• Ultrasonic degradation. 
• Stress-induced chemical degradation. 
• Freezing and thawing degradation. 
In its broader sense, the mechanical degradation of a polymer covers fracture phenomena, 
as well as chemical changes induced by mechanical stress (Grassie, 1956). 
Polymer degradation in solution 
A stress~induced reaction can occur if the polymer solution is subjected to high-speed 
stirring, shaking, turbulent flow or ultrasonic treatment. In systematic studies, stress-
induced reactions are frequently induced by forcing a polymer solution to flow through a 
narrow capillary tube or by treating the polymer solution in a rotational viscometer, or a 
high-speed homogenizer (Kendrick et al, 1989). If polymer in solution is subjected to the 
influence of ultrasonic waves, then, generally, main-chain degradation occurs. With the aid 
of ultrasonic generators, high molecular weight polymer samples can be converted to low 
molecular weight material (Gressbach and Lehmann, 1999). 
The mechanism of ultrasonic degradation is explained as follows (Basedow and Ebert, 
1977). When a liquid is exposed to ultrasonic waves of high intensity it expands and gives 
rise to a negative pressure causing any dissolved gas to form bubbles. The presence of gas 
7 
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IS the driving force for the generation of bond ruptures. Main-chain rupture in 
macromolecules is thought to be induced by these shock waves, which are assumed to 
cause a rapid compression with subsequent expansion of the liquid. 
Chemical Degradation 
Changes in polymers may also occur due to conditions other than mechanical forces (e.g. 
oxidation, irradiation, other chemical reactions, etc.) thereby altering their properties. 
Chemical degradation of a polymer containing a heteroatom linkage in the main chain may 
occur by the attack of solvolytic or oxidative reagents due to main-chain scission, thus 
causing changes in the physical properties. The solvolysis reactions involve the breaking of 
C-X bonds, where X designates a hetero atom, such as 0 , N, P, S, Si or halogen, under the 
influence of the solvent, YZ such as as water, alcohol (R-OH), etc, as indicated by Fig 1.2. 
I I 
- c - -c- y 
I I I X + YZ X + -C-
I I I 
- c - z 
I 
Figure 1.2 General equation for the solvolysis reaction of a polymer containing 
a hetero atom X by solvent YZ 
Oxidative degradation of a polymer proceeds by a free radical chain mechanism consisting 
of three important steps: initiation, propagation, and termination. The initiation step may 
be effected by thermal or photochemical action, or by the participation of metal ion 
catalysis or peroxidic substances, while oxygen participates in the propagation step 
8 
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(Conley, 1970). The term biodegradation in relation to a polymer refers to the degradation 
and assimilation of organic polymers and compounds by living organisms, principally 
microorganisms such as fungi, bacteria and actinomycetes. The term can be enlarged to 
include attack by all forms of living things (Economy and Mason, 1970). 
Degradation of Silicone polymers 
Silicone polymers (such as polydimethylsiloxane) generally are viscous liquids at room 
temperature, depending on the molecular weight. Their maximum use temperature is 
designated in the region 150-200 o C, mainly because of the reduction in viscosity with 
increasing temperature (Conley, 1970). Degradation of polydimethylsiloxane has been 
demonstrated following heating at 300°C. Volatile products have been detected by gas 
chromatography as shown in Figure 1.3. The products D3, 0 4, etc, have been identified as 
the cyclic trimer, tetramer, etc, up to heptadecamer D11 (Grassie and Scott, 1985). 
~ 
= 0 
. , 
it· e. 
'"' 0 . 
t) 
~ 
... 
G.) 
03 
o • 
· a:~. .  
. 0 s 
Ds 
D6 
D, 
Du 
· to 15 20 25 30 '• 35 40 45 
· Time, min 
Figure 1.3 Gas chromatography trace of the volatile products from thermal degradation of 
PDMS (Grassie and Scott, 1985) 
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While GLC is useful for the detection of volatile products from the polymer degradation 
process, it gives no information about the residual material. Thermogravimetry (TG) is a 
technique for the measurement of the change in weight of a material as the temperature of 
its environment is varied in a controlled manner. TG was used to examine a series of 
PDMS samples with different average molecular weights and with some variation of the 
preparation (Husam et al, 1990). In Fig 1.4, curves 1 to 4 are for materials which differ 
only with respect to their 'average molecular weight. It can be seen that the threshold 
temperature at which significant weight loss starts to occur, increases with increase in 
molecular weight of the polymer. The weight loss can be interpreted as breakdown of the 
polymer, yielding volatile products of lower molecular weight (Grassie, 1985). 
Curve 5 displays the weight loss for sample 2 after end-capping, which means treatment to 
silanise any free Si-OH groups with trimethylsilyl chloride. The end-capping treatment 
has imparted greater stability to the polymer. On the other hand, treatment of sample 2 
with 5% potassium hydroxide (curve 6) produces a polymer that breaks down at much 
lower temperature. 
~ 
i 
.. 
;1: 
Cl) 
;::s 
:9 
~ 
100 200 300' . 400 
. Temperature, ~C 
Figure 1.4 Thermogravimetric analysis curves for polydimethylsiloxanes of different 
number average molecular weights: 
1, 94500; 2, 111500; 3, 183000; 4, 258000; 5, 2 end capped; 6, 2 + 5% KOH 
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Although the designated structure of PDMS does not show the existence of - OH groups, it 
is found that a very small proportion of the molecules do bear terminal -OH groups. The 
reason for this is believed to be partial hydrolysis of -Cl substituents in the preparation of 
the siloxanes (West, 1997). 
It is postulated that terminal hydroxyl groups play an important role in initiating the 
degradation reaction of s'ilicone polymers (Grassie, 1964). The following series of 
reactions (A - D) in Figures 1.5 - 1.9 are now generally accepted as representing the 
mechanisms whereby small molecular weight compounds break off from PDMS (John, 
1990). 
CH3 CH3 CH3CH3 CH\3CH3 \I \I I 
- Si--Q-Si---0- Si ~ d-si- J v __ _/ ~ 
et-r3 CH3 
CH3, )CH '~~/ 3 
Si Si 
CH{! )~ ~9H3 6 + - Si-QH 
~i 
c/, "a,3 
Figure 1.5 
hydroxyl group 
Reaction A - Formation of cyclic siloxane trimer involving terminal 
11 
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Reaction A shows the hydroxyl groups reacting with the third Si atom from the chain end 
leading to a trimer. Higher oligomers can be formed by analogous reaction with points 
further from the chain ends. Although end-capping (blocking of free Si-OH groups) 
imparts stability to the polymer, when degradation occurs, the products are the same as 
for hydroxyl terminated chains. Thus a comparable mechanism may be suggested in 
which a second silicon atom replaces the hydrogen atom in the four-membered ring 
transition state but also requiring participation of an OH donor (Grassie, 1985). 
CH~ JH~ C~37H3 CH3 , ~H '~"""-../ 3 
-si ...J._J -s~~---
-'CJ-si-0-si 
cH{ cf-i3 cH{ 2H3 
Si Si cH~ I ) --cH3 c~3 9H3 
6 + -si- 0 -~i 
c( "cH3 
Figure 1.6 Reaction B -Formation of cyclic siloxane trimer from a mid-chain reaction 
Acceleration of the degradation reaction by KOH is probably due to hydroxyl wns 
providing the driving force for the polymer-breaking reaction. 
CH3 C~ CH3 CH3 \/ ~). \1 ~i--9-Si--O 
HO- -Dd;-0-~i 
cH{ CH3 cH{ CH3 
Figure 1. 7 Hydroxide ion catalysis of PDMS degradation 
12 
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When the reaction was carried out in the presence of KOH, mass spectrometry revealed a 
minor product with a molecular weight of 430. The only reasonable structure corresponds 
to product C (Fig 1.8) 
C{i3 _c H3 C~3 C H3 
""( ./ CH3 CH \ / 
St-0, I I 30-Si 
/ ,,, / "' 0 St-0-Si 0 
'si-o/ 'o s ·/ I\ -I 
CH3 CH 3 I CH CH 3 3 
Figure 1.8 Postulated structure of product C 
It has been proposed that the first step in its formation involves a siloxyl ion which reacts 
to form methane, which is also formed in the hydroxyl ion catalyzed reaction. A similar 
reaction further along the chain would liberate product C (Grassie, 1972) 
CH3 CH3 1. ~1. -
-SJ-0-SJ-0 
I I 
CH3 /CH3 
HO-
CH3 I 
____ ..,.. -Si-0 + 
I 
CH3 
13 
CH3 I 
HO-Si-0-
1 
CH3 
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H-~) 
(HH, C~ 9H, ~~ . CH3 .A)-Si "-
CH3 '-..._ (0 -s,"" 1./ o + CH
4 
+ OH-
s· o-o -St" _ / 
/ '- s·/ '0--si -~ 'O-t I I' 
CH CH3 3 
Figure 1.9 Reaction D 
The replacement of a portion of the methyl groups by phenyl groups is used to improve 
the thermal stability of silicones. The behaviour of poly(methyl phenylsiloxane) provides 
a clue to the reasons for this. Benzene is formed in small amounts and the polymer 
becomes insoluble on heating to 150°C (David, 1975). In addition, thermogravimetric 
analysis of this polymer demonstrated that the higher the molecular weight, the lower is 
the stability and that the stability is decreased by end-capping. 
In the hydrolysis reaction of PDMS, it is assumed that normal hydrolysis of Si-0-Si bond 
is occurring, producing silanol (SiOH) groups on the surface of the polymer. Because the 
remaining polymer is unchanged beneath this layer, this hydrolysis would affect only the 
surface state (Wallace et al, 1993). 
Due to the insolubility of PDMS in water and its high adsorption coefficient, liquid PDMS 
discharged as effluent will adsorb to particulate matter and, therefore, will become a 
component of sewage sludge during waste water treatment. The subsequent environmental 
fate of PDMS will depend on the fate of the sludge. Due to increasing practices of soil 
amendment with sewage sludge the principal environment compartment receiving PDMS 
14 
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fluids is the soil. Degradation of PDMS is a common process taking place in many 
different types of soils. It occurs through a unique combination of environmental 
degradation process (Grassie, 1966). The initial hydrolysis product, dimethylsilanediol 
(DMSD), is either biodegraded, or evaporated into the atmosphere, where it is 
subsequently oxidized in the presence of sunlight. The end products in both cases are 
expected to be C02, Si02 and H20 (Xu et al, 1998). 
1.5 Analysis of Polydimethylsiloxane 
Although Simethicone is a widely used ingredient in pharmaceutical formulations, it has 
been generally regarded as similar to an excipient, rather than an active component. Hence 
methodology for the chemical analysis of the quantity of Simethicone in such 
formulations is limited in the pharmaceutical literature (Kala et al, 1997). Another factor 
may be that the quantitation of this type of ingredient frequently proves to be quite 
challenging to the analytical chemist (Hidaca et al, 1970). Often the ingredient is present 
in low concentration in a formulation of complex composition. For example it may 
contain ingredients such as water, glycerin, stearic acid, mineral oil, acetylated lanolin 
alcohol, salts and preservatives, none of which have readily identifiable analytical 
characteristics (Khafi et al, 1996). 
The BP describes a test for the identification of dimethicone by viscosity and infrared 
absorption spectrophotometry, but no quantitative tests are given (BP, 2000). The USP 
(2000) describes assays for the silicon dioxide content of Simethicone by gravimetry, and 
the PDMS content by Fourier Transform Infrared Subtraction (FTIR) spectrometry. 
Consequently FTIR has become the principal method for quantitation of PDMS (Torrado 
et al, 1999). 
The only reported chromatographic analysis of PDMS involves the use of gel permeation 
(Andersson et al, 1989). The advantages and limitations of these methods are described 
below. 
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1.5.1 Gel Permeation Chromatography of PDMS 
Gel Permeation Chromatography (GPC) is a technique for the separation of components 
of a molecule according to their molecular size. The range of molecular weights which can 
be resolved into individual components is determined by the pore size of the gel stationary 
phase. As applied to the determination of PDMS in Simethicone Emulsion, the sample 
preparation is straightforward (Andersson et al, 1989). An aliquot of the emulsion was 
accurately weighed and dissolved in methyl isobutyl ketone. After ultrasonication and 
centrifugation, the supernatant was injected on to the GPC column. The analytical column 
(300 mm x 7.7 mm i.d.) contained polystyrene-divinylbenzene, I 0 j..tffi particles, of mixed 
pore size with a molecular weight working range of 1000-106 (PL-gel; Polymer 
Laboratories, Amerst, U.S.A.). The mobile phase of 100% toluene was delivered at a flow 
rate of 1.0 mL/min. The injection volume was 30 j..tL. Detection of PDMS was achieved 
using a refractive index detector. The separation of PDMS by this procedure is shown in 
Figure 1.1 0. Several formulations containing Dimeticone were assayed after construction 
of a standard curve with PDMS reference standards. 
~­
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Figure 1.10 Separation of PDMS (retention volume 7.2 ml) by gel permeation 
chromatography (A) PDMS Standard and (B) Sample (from Andersson et al, 1989). 
16 
------- ------- -------
Cltapter 1 Introduction 
.·.·,:=::.;:!.:: · 
In the above chromatograms, A shows the separation of standard PDMS as in Dimeticone, 
while B shows the separation of PDMS in a pharmaceutical formulation containing 
Dimeticone. The void volume, Yo, of the column was determined by use of a high-
molecular weight PDMS (MW > 1 06) and was found to be 5.5 ml. The total permeation 
volume, Vt, determined by use of chloroform (dissolved in the mobile phase) was found 
to be 13.5 ml. The retentioh volume, VR, for the PDMS in pharmaceutical samples was 
7.20 ± 0.032 ml (n = 32) (Andersson et al, 1989). 
The GPC method utilizes a refractive index detector which has disadvantages due to its 
poor sensitivity. The RI detector is also much less suitable for gradient elution due to the 
refractive index change that occurs as the solvent composition changes. It is also sensitive 
to fluctuations in cell pressure, flow rate and the temperature of the mobile phase. 
1.5.2 Fourier Transform Infrared Spectrophotometry (FTIR) 
The British Pharmacopoeia (BP, 2000) includes FTIR as a component of the identification 
procedure for PDMS in Dimeticone. The FTIR spectrum is compared to one obtained 
with a certified standard sample. However the BP advises that the region of the spectrum 
from 750 to 850 em·' should be disregarded since slight difference may be observed 
depending on the degree of polymerization of the PDMS. This is also stated in the USP 
(2000) which presents an assay for analysis of PDMS in Simethicone by infra red 
spectrometry. This assay quantifies the amount of PDMS, and two additional tests are 
described to determine the silicon dioxide content and the defoaming activity. 
The USP procedure involves the addition of 50 ml of dilute hydrochloric acid to neutralise 
the antacid components of the formulation, followed by extraction of the PDMS with 25 
mL of carbon tetrachloride. After extraction, the organic layer is dried with anhydrous 
sodium sulfate and examined in a 0.5 mm path liquid cell by FTIR. The infrared spectrum 
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of PDMS (Fig 1.11) exhibits a characteristic doublet at 1097.6 and 1014.6 em·• due to 
stretching and bending of Si-0 bonds in addition to a sharp band around 1265 cm· 1 due to 
CH3-Si vibrations. Quantitative use of the 1265 cm·1 band is precluded in other solvents 
by very strong solvent absorption in that area (Durkin, 1998). 
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Fig 1.11 IR Spectrum of standard PDMS (A) and formulation E (B) (from Torrado 
et al, 1999) 
A modification of the USP procedure for Simethicone was developed and validated by 
Torrado et al (1997). This method eliminated the acidic aqueous phase by direct 
dissolution of the formulation in the solvent carbon tetrachloride with the aid of a lengthy 
sonication period. The sample then was filtered into the 0.5 mm IR cells and examined at 
the wavelength of maximum absorbance of 7.9 J.lffi ( 1265 cm-1). A blank is prepared with 
carbon tetrachloride and used to zero the instrument. 
All formulations showed a spectrum similar to the one obtained with standard PDMS, as 
shown in Figure 1.12 for USP standard PDMS and two of the formulations tested, B and 
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D. The FTIR method was used for the quantitation of Simethicone in lotions, capsules and 
tablets. For the samples tested, reliable results are generated only when a simple matrix 
was not involved. It was found that quantitation of PDMS in complex emulsions and 
suspensions such as those containing antacid components requires careful sample handling 
and precise background subtraction of the sample matrix (Torrado et al, 1997). 
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Figure 1.12 FTIR spectroscopy of standard simethicone (-), formulation B (-.-) and 
formulation D (-- -) (from Torrado et al,1999). 
In the case ofthe more complex formulations, the peak at 1014.6 cm-1 is recommended for 
the quantitation of PDMS since there is less interference from both solvent and blank 
formulation at this wavenumber. 
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With a more complex procedure involving the use of liquid-liquid extraction followed by 
column liquid-solid extraction prior to FTIR analysis and matrix subtraction, a slightly 
positive bias due to matrix interference was still obtained. With the USP reference 
standard PDMS (Figure 1.11 ), the peak at 1097.6 cm-1 for formulation E is just slightly 
smaller than the peak at 1014.6 cm-1, while the sample spectrum shows the opposite. This 
is most probably due to blank matrix absorption. Where the blank interference is constant, 
it still produces more significant quantitation errors at lower concentrations (Sabo et al, 
1983). 
1.5.3 Deficiencies of the USP method for analysis of PDMS 
Although the FTIR method appears to provide an adequate quantitation procedure for 
PDMS, the interferences caused by matrix components are highly variable, and the 
handling of the small volume IR cells with extremely volatile solvents requires great 
care. A further and very important consideration is that these methods are not stability 
indicating, a requirement that emerges in regard to shelf-life determination of 
therapeutic goods. For the latter purpose, a chromatographic method appears desirable 
but the separation power needs to be greater than reported by the published gel 
permeation technique. 
For greater sensitivity and selectivity in development, the chromatographic method 
involved would be enhanced by a detection technique that has applicability to 
compounds without UV -absorbing properties, and operating over a wider separating 
range than the refractive index detector. A description of current possibilities follows. 
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1.5.4 Detection of substances without UV chromophore in liquid chromatographic 
analysis 
Ultraviolet absorption detection (UVD) is the simplest form of detection of the separated 
components in liquid chromatography and the most universally applicable in 
pharmaceutical analysis, but clearly requires that the components have suitable UV 
absorbance characteristics. Many analyses of weak UV absorbers have been developed 
with UVD at shorter wavelengths (less than 220 nm) where solvent and impurity 
absorptions are prone to occur, so that gradient elution becomes more difficult as the 
baseline changes steeply. 
Indirect detection by means of chemical reaction to add a UV absorbing group has also 
been used, but only to a limited extent since an appropriate reactive group is required. 
Other methods require the molecule to have the appropriate properties to respond, such as 
fluorescence (Lafosse et al, 1987), or electrochemical detection involving oxidation or 
reduction of the solute (Leung, 1989). Refractive index detection (RI) and more recently, 
the evaporative light scattering detector (ELSD) are being used routinely for drugs which 
are weakly absorbing or contain no UV chromophores (Asmus and Ebert, 1984). 
The refractive index detector , being a bulk property detector, has a significantly lower 
sensitivity than the UV detector but more nearly approaches the universal detector in the 
sense that it will detect any solute that has a refractive index different from that of the 
mobile phase. It also finds a major application in the detection of solutes that do not have 
UV chromophores (McCrossen et al, 1998). The refractive index detector has a relatively 
narrow linear dynamic range of two to three orders of magnitude and it is thus less 
suitable than the UV detector for the quantitative analysis of a mixture having solutes 
present over a wide concentration range. Due to the change in refractive index as the 
solvent composition changes, the detector is much less suitable for gradient elution 
development than the UV detector. The RI detector is also very sensitive to fluctuations in 
cell pressure, flow rate and the temperature of the mobile phase. If the ambient 
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temperature changes during a chromatogram then significant drift will almost surely 
result. 
Thus the refractive index detector, although relatively simple to operate, is probably the 
most difficult instrument to use at maximum sensitivity due to its general instability under 
the conditions. If the pump employed is reciprocating in action, this often produces short 
term noise in the detector ~utput and may in fact be the limiting factor with respect to 
sensitivity. 
The mass spectrometer may be classed as a universal detector, but it has an upper mass 
limit because it relies on the solute molecule being ionized in the gas phase. Thus non-
volatile high molecular weight compounds such as polymers are not detected unless 
initially degraded to lower molecular weight units (generally less than 2000 Daltons). 
1.5.5 The Evaporative Light Scattering Detector 
A new alternative for routine LC detection of solutes without a significant a UV 
chromophore is the Evaporative Light Scattering Detector (ELSD) (Conforti et al, 1993). 
Unlike the RID, low-wavelength UVD and mass detection, the ELSD is able to employ 
multisolvent gradients for improved resolution and faster separations, without the baseline 
problems common to RID and UV detection (Colin et al, 1983). 
The detection principle of the ELSD involves nebulization of the column effluent to form 
an aerosol, whereupon the solvent vaporizes to produce a cloud of solute droplets, which 
are detected by light scattering (Colin et al, 1984). The major components of the system 
are the nebulizer, the heated drift tube, and the light scattering cell as shown in schematic 
form in Figure 1.13. 
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Fig 1.13 Key features of the Evaporative Light Scattering Detector 
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Nebulizer 
The outlet of the analytical column is connected directly to the nebulizer. Inside the 
nebuliser, nitrogen gas at high pressure forces the column effluent through a fine 
hypodermic needle to produce an aerosol containing a uniform dispersion of mobile phase 
droplets. Uniform nebulization is the key to precision in the ELSD. Solvent flow and gas 
• 
pressure in the nebuliser are monitored and controlled to ensure a consistent dispersion of 
droplets for reproducible results (De Mann et al, 1984 ). 
Drift Tube 
In the drift tube, the volatile components of the mobile phase aerosol are evaporated. The 
non-volatile components in the mobile phase continue down the drift tube in the form of 
even smaller particles to the light scattering cell where a response is generated. The 
ELSD works with any volatile mobile phase independent of its optical properties. 
Solvents are not required to be UV transparent, or to have refractive indices significantly 
different from the solute sample. Sample solvents can be chosen on the basis of their 
solubility or separation characteristics. Nonvolatile impurities in the mobile phase or 
nebulising gas will produce noise. The operational temperature is important as detector 
noise will also increase if the mobile phase is not completely evaporated. On the other 
hand, too high a temperature will cause disruption to the sample droplets by uneven 
evaporation. The optimum temperature for the drift tube is determined by observing the 
signal to noise ratio with respect to temperature. 
Light Scattering Cell 
The nebulized column effluent, depleted of volatile components, enters the light scattering 
cell where the solute particles are irradiated with the light from a laser diode. The scattered 
light is detected at 90" to the incident laser beam by photodiode, producing an electrical 
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signal which is sent to the analog outputs for collection. A light trap is located 180 o from 
the laser to collect any light not scattered by particles in the aerosol stream. 
The amount of light scattered depends on the following factors: ( 1) The intensity of the 
incident light. (2) The angle of observation. (3) The ratio of the particle radius to 
wavelength. (4) The number of scattering particles. (5) The size of the scattered particles 
(Guiochon et al, 1988). 
ELSD Operating Parameters 
The ELSD has a number of operating parameters, which need to be optimized for each 
application. A compromise between the mobile phase flow, nebulizer gas flow, and drift 
tube temperature must be chosen to maximize the sensitivity (Herbreteau et al, 1990). 
< 1 > Nebulizer gas flow rate 
The nebulizer gas flow rate determines the mobile phase droplet size, flow rates from 0.5 
to 4.00 standard litres per minute (SLPM) can be selected. A higher flow rate will produce 
smaller droplets to enhance evaporation, but these scatter less light, reducing sensitivity. 
Thus the lowest acceptable gas flow rate producing the largest signals should be 
determined. A stable gas flow rate is critical for good reproducibility. It has been stated 
that a secondary pressure regulator may be needed if the gas source is unstable 
(Oppenheimer and Mourey, 1985). 
< 2 > Mobile phase flow rate 
The mobile phase flow rate has a direct effect on the choice of the gas flow rate and drift 
tube temperature. A higher mobile phase flow rate requires a higher gas flow rate and a 
higher drift tube temperature. It is therefore advantageous to use the lowest mobile phase 
flow rate possible, and this can be assisted by the use of narrow bore columns without 
affecting retention times. 
25 
Chapter 1 Introduction 
< 3 > Drift tube temperature 
The selection of the drift tube temperature depends mainly on the volatility of the mobile 
phase, but it is also affected by the mobile phase and gas flow rates. Aqueous solvents 
require higher temperatures than organic solvents while a lower gas flow rate produces 
larger droplets, and therefore, requires higher temperatures. The lowest temperature that 
produces an acceptable, low noise baseline should be used. When gradient elution of the 
multi-component mixture is being used, a compromise may have to be reached with respect 
to the drift tube temperature. At this stage, no instrument has been developed whereby the 
drift tube temperature can be programmed to change in the course of an analysis. 
The advantages and limitations of ELSD 
The ELSD works with any volatile mobile phase independent of its optical properties. The 
mobile phase is not limited to the UV transparent, or to those which have refractive indices 
significantly different from sample. Mobile phases are chosen only based on sample 
solubility and volatility (Oppenheimer and Mourey, 1985). 
The ELSD offers the following advantages: 
1. The baseline is not affected by solvent, column and laboratory temperature 
2. Gradient elution shows no significant baseline shift, so it can be used for improved 
resolution of components 
3. A functional group is not required in the analyte. 
4. The detector generally responds to sample concentration (mass) directly. 
The chromatographic requirements of the ELSD are similar to those for a LC-MS system, 
so that the ELSD is useful for developing the chromatographic conditions off-line prior to 
the LC-MS. The universal response of the ELSD gives a closer representation of sample 
mass than the UV detector for unknown substances and impurities (Letter, 1992). All 
sample types are detected with nearly equivalent response factors. Impurities identified 
during chemical characterization are detected according to their actual mass 
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concentrations (Letter, 1993). Unknown components can be approximately quantified by 
comparison to internal standards because the mass responses are nearly equivalent. 
Disadvantages: 
The major limitation of the ELSD is that the sensitivity of the detector is largely affected 
by the volatility of the analyte. The sample must be less volatile than the mobile phase and 
not evaporated at the selectecl drift tube temperature. Also, the ELSD is not able to operate 
with non-volatile solvents, such as salt-buffer solutions. Volatile buffer components, such 
as acetic acid, trifluoroacetic acid (TF A) or formic acid combined with ammonium 
hydroxide may be used as long as the concentration is below 0.1 %. 
The ELSD is therefore a powerful new tool for HPLC and GPC in that it can detect lipids, 
carbohydrates, polymers, fatty acids, oils, and other difficult samples precisely and 
accurately 
1.6. Aim and Scope of the Project 
The use of Simethicone as a therapeutic ingredient in pharmaceutical formulations has led 
to a requirement for efficient stability-indicating analytical methods for its quantitation. 
To date, the standard method for the analysis and quantitation of PDMS has been infrared 
spectroscopy (USP, 2000). If the matrix is simple, reliable results for the amount of PDMS 
are generated by this method. However, emulsions and suspensions containing PDMS 
require efficient extraction but still show background effects due to the sample matrix, 
particularly when antacid components are present (Olivie and Atkinson, 1996). 
Additionally the method is not stability indicating. An alternative is therefore needed for 
the analysis of simethicone as part of the quality control procedure in the pharmaceutical 
industry (Mihaly et al, 1982). 
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The objective of this project was to develop and validate a stability-indicating assay for 
Simethicone in liquid and solid antacid formulations. Liquid chromatography was the 
method of choice with its potential for the separation of components of a mixture. Because 
of the lack of UV chromophore in PDMS, the key component of the instrument is the 
evaporative light scattering detector (ELSD). When fully validated, the assay should be 
suitable for routine use in the quality control laboratory. The validation process required 
the determination of the method precision, system precision, recovery, linearity and 
working range, together with selectivity and ruggedness of the assay. The additional 
objective was to determine whether the assay method could be used in a stability 
indicating fashion for purposes of shelf-life assessment of pharmaceutical formulations 
containing PDMS. 
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2.1 Materials 
2.1.1 Chemicals and reagents 
I 
Hydrochloric acid (AR) and methanol (AR) were supplied by Asia Pacific Specialty 
Chemicals Limited (Sydney). Dichloromethane (AR) and chloroform (AR) were supplied 
by Selby Scientific Limited (Sydney). Acetonitrile (HPLC grade) and sodium sulfate 
anhydrous (AR) were from Mallinckrodt, Australia. Other chemicals used were of 
analytical reagent grade (Merck, BDH and Ajax Chemicals, Sydney). Paracetamol was of 
analytical grade and was supplied by Sigma-Aldrich (Sydney, Australia). Water was 
double-distilled from an all-glass apparatus. Nitrogen gas of high purity grade was 
supplied by BOC (Sydney). The gas was passed through an in-line filter during use. 
2.1.2 Silicone polymer samples 
The following materials were provided by PfiZer Warner-Lambert Pty Ltd 
•!• Polydimethylsiloxane USP reference standard 350: a clear, viscous oil, it is a 
mixture of fully methylated linear silicone polymers containing repeating units of 
dimethylsiloxane. In the following, this material is referred as USP PDMS. 
•!• Simethicone Emulsion: manufactured by Dow Corning Corporation. It is composed 
ofPDMS, silica, stearate emulsifiers, benzoic acid ester preservatives and water. It is a 
thick white paste with a slight characteristic odour and with viscosity of 25000 
centistokes. One batch Log# 161097-D, was used in all experiments. The content of 
PDMS in this batch was 27.8% (Dow Corning Corporation). 
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•!• Mylanta Liquid Antacid Suspension: a formulation of Simethicone and antacids in 
water, manufactured by Pfizer Warner-Lambert Pty Ltd according to the following 
rec1pe: 
Magnesium Hydroxide 
Aluminum Hydroxide 
Simethicone 
Butyl Hydroxybenzoate ' 
Propyl Hydroxybenzoate 
400 mg/ 10 mL 
400 mg/ 10 mL 
40 mg/ 10 mL 
0.2 mgl mL 
0.3 mg/mL 
Various batches of the formulation were used. 
•!• "Mylanta Placebo" Matrix: contained all of the ingredients of Mylanta liquid 
antacid suspension except Simethicone. 
2.2 Apparatus 
The HPLC system was supplied by Shimadzu Scientific Instruments (Sydney) and 
consisted of a Shimadzu LC-1 OA TVP liquid chromatograph pump and solvent delivery 
system. A Shimazdu SPD-M10 AVP variable wavelength diode array detector and 
Alltech evaporative light scattering detector model 500 (Alltech Associates, Sydney) were 
used together with a SPD-1 OADVP Autoinjector. The system was operated through a 
Shimadzu CBM-1 OA communication module and the software used was LC-1 0 
workstation. The data handling system included a Daewoo Pentium computer and a 
Hewlett Packard Deskjet 560 printer. For all HPLC analyses, an Alltima C8 reversed-
phase column (Alltech Associates, Sydney) with dimensions 250 x 4.6 mm was used. The 
column packing was of 5 f..liD particle size. 
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2.3 Methods 
2.3.1 Mobile phase and sample preparation 
The mobile phase compositions for the different analysis were as follows: 
1. For the analysis of paracetamol, an isocratic mobile phase of 30% water and 70% 
methanol was used at a flow rate of 1.0 mL!min. 
2. For analysis of PDMS, various binary gradient elution programs were used based on 
acetonitrile and chloroform. In general, the programs began with a solvent mixture of 
about equal parts then the chloroform content was increased. The main gradient program 
used was initiated at 55% chloroform (45% acetonitrile). The concentration of chloroform 
was ramped up to 85% over 5 minutes, then the concentration of chloroform was taken 
down to 55% in 5 minutes. The system was equilibrated at 55% chloroform for another 5 
minutes. The flow rate was 1.0 mL/min. 
Sample preparation: 
1. Paracetamol standard solution 
A stock solution of paracetamol at a concentration 2.00 mg/mL in double distilled water 
was prepared with a small amount of methanol (2%) to aid dissolution. From the stock 
solution, a series of dilutions (1.6, 1.28, 1.0, 0.5, 0.26 mg/mL) were prepared for injection 
into the HPLC system. 
2. PDMS standard solutions 
Approximately 100 mg of USP PDMS was accurately weighed into a 25 mL volumetric 
flask. The sample was dissolved with chloroform and made up to the mark. 1.0, 2.0, 3.0 , 
4.0, and 5.0 mL of the diluted solution were transferred into separate 10.0 mL volumetric 
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flasks and diluted with chloroform, mixed well and used as the standard solutions. For 
each sample, the area of the PDMS peak (average of the three injections) was plotted 
against the PDMS concentration to produce the PDMS standard curve. 
3. Analysis ofPDMS in Mylanta Liquid antacid suspension 
The principle of all PDMS analysis methods was the same. The sample was treated with 
concentrated hydrochloric aeid to neutralize the anti-acid components. Dichloromethane 
was then used as extraction solvent for the separation of PDMS. The detailed procedure is 
as follows: 
The Mylanta Liquid sample was mixed thoroughly. Approximately 10.0 mL of the sample 
was accurately weighed into a 50 mL beaker, then 15 mL of hydrochloric acid added. The 
solution was transferred into a 50 mL separating funnel. The beaker was washed with 15 
mL dichloromethane and the washings transferred into the same separating funnel. The 
combined mixture was shaken vigorously for 2 minutes and then allowed to separate into 
two layers. The bottom layer was collected into a 1 00 mL volumetric flask and the top 
layer was extracted with another two portions of 15 mL dichloromethane. The 
dichloromethane portions were combined, 5.0 gram of anhydrous sodium sulfate was 
added and the solution was allowed to stand at room temperature for 2 hours with 
occasional shaking. The dried solution was filtered through a 0.5 em diameter Whatman 
No.1 filter paper and collected in a 100 mL round bottom flask. The filter was washed 
with another 5 mL of dichloromethane. The combined dichloromethane was evaporated to 
dryness under reduced pressure on the rotary evaporator. The residue was redissolved 
with chloroform to a final volume of 25.0 mL. Aliquots of this solution were filtered 
through a 0.45 ~m Gelman PTFE membrane syringe filter unit into the HPLC injection 
vial. For each sample, the peak area of the PDMS peak in the HPLC-ELSD system was 
obtained as the average from three injections. 
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4. Blank placebo matrix sample preparation 
Approximately 10 mL of the Placebo matrix was weighed into a separating funnel, and 
the same extraction procedure as in (3) was followed. 
5. Standard samples for Mylanta analysis 
Five different amounts (approximately 67, 100, 133, 167, 200 mg) of Simethicone 
Emulsion were accurately weighed into 50 mL beakers, and 10.0 mL Mylanta placebo 
matrix was added and mixed. The extraction procedure with dichloromethane was 
followed exactly as described above in (3). After extraction, evaporation and redissolving 
in chloroform, the five samples were filtered and analyzed by the HPLC-ELSD system. 
The peak area (average of three injections) was plotted versus the amount of Simethicone 
Emulsion taken to produce the Simethicone Emulsion Recovery Standard Curve. 
6. PDMS content of Simethicone Emulsion 
Approximately 133 mg Simethicone Emulsion was weighed accurately and treated with 
the same procedure as described in (3), and analyzed with the PDMS standard curve 
obtained in (2). 
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3.1 Optimisation of ELSD parameters for HPLC analysis 
Achieving optimised performance of the ELSD depends on setting the parameters 
appropriate to the application. The optimum drift tube temperature and gas flow rate 
settings depends on the volatility of the mobile phase and its flow rate. The higher the 
volatility, the lower the gas flow rate and drift tube temperature required. It is important 
that the temperature of the drift tube be sufficient to enable the mobile phase to vaporise 
quickly and produce a stable baseline. The gas flow rate is varied to adjust the size of the 
droplet and lead to the maximum detector response. For the initial characterisation of the 
ELSD, paracetamol was used as analyte. Paracetamol was chosen in order that the 
response of the ELSD could be compared with that of the UV detector. The Alltima C8 
column was used with the mobile phase of water : methanol (30:70) at a flow rate of 1.0 
mL/min. When desired, eluant from the column could be passed first through the UVD 
set at 265nm and then to the ELSD. The nebulizer gas flow rate to the ELSD was set at 
2.0 litres per minute while the drift tube temperature was varied from 90 to 11 0°C and 
the average peak area at each temperature was recorded. 
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Table 3.1 Peak areas recorded (arbitrary units) for Paracetamol at various ELSD drift 
tube temperatures (gas flow rate 2.0 Llmin, mobile flow rate 1.0 mL!min). 
Drift tube Peak Area Peak Area Peak Area Average peak area ± SD 
Temp (°C) Injection 1 Injection 2 Injection 3 
90 25.0 I 25.2 25.7 25.3 ± 0.4 
95 25.0 27.5 26.5 26.3 ± 1.3 
100 20.0 20.0 19.0 19.7 ± 0.6 
105 16.0 16.7 16.8 16.5 ± 0.4 
110 9.0 9.6 9.8 9.5 ± 0.4 
115 5.5 5.3 5.5 5.4±0.1 
From Table 3.1, it can be seen that when the temperature was set at 95°C, the detector 
gave the maximum response. Hence the drift tube temperature was set at 95°C for 
subsequent experiments with paracetamol as analyte. Since the detection process 
involves the scattering of light by the solute in particle form after evaporation of the 
mobile phase, the size of the sample particle can affect the detector response. The 
nebulization process acts to regulate the column effluent, and the factors that affect the 
process are the gas and mobile phase flow rates. The nitrogen gas flow rate to the ELSD 
was varied from 1.5 L/min to 4.0 Llmin. The detector responses are compared in Table 
3.2 
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Table 3.2 Peak Area recorded (arbitrary units) for Paracetamol at various gas flow rates 
for the ELSD (drift tube temperature 95°C), other conditions as in Table 3.l. 
Gas flow rate (Limin) Peak Area 1 Peak Area 2 Average Peak Area ± SD I 
1.5 23.8 24.0 23.9 ± 0.1 
2.0 25.0 27.0 26.0 ± 1.4 J , 
2.5 27.0 24.8 25.9 ± 1.1 I 
3.0 25.0 23.5 24.5 ± 1.1 
3.5 19.0 21.0 20.0 ± 1.4 
3.9 16.0 17.0 16.5 ± 0.5 
Although the variations between individual chromatograms were rather large, a gas flow 
rate of 2.00 Llmin was chosen for use when the drift tube temperature was 95°C. In the 
next step, the mobile phase flow rate was varied from 0.8 to 1.0 mL/min. No significant 
difference in the peak area was found, so the mobile phase was set at 1.0 mL/min in 
subsequent experiments. 
Comparison of ELSD and UVD response levels 
The HPLC system was set up with the UV detector and ELSD in series so that the same 
amount of eluate passed through both detectors. Paracetamol was used as analyte to 
check the detector response, with the conditions as established above (gas flow rate 2.0 
L/min, mobile phase flow rate 1.0 mL/min, drift tube temperature 95°C. The wavelength 
of the UV detector was set at 265 nm to obtain a suitable peak size. The standard curves 
from the UVD and ELSD were generated using peak area versus concentration of 
paracetamol in mg/mL, as shown in Figs 3.1 and 3.2. 
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Fig 3.2 Standard curve for Paracetamol analysis using UV detector at 265 run 
Because paracetamol has a relatively high molar absorptivity, the UVD is capable of 
detecting the drug in concentrations below 0.1 mg/mL as seen in Fig 3.2. On the other 
hand, the response of the ELSD shows a non-linear section at paracetamol concentrations 
below about 0.2 mg/mL. The standard curve is better fitted by a second order polynomial 
at low concentration. This is presumably due to the poor light scattering characteristics 
of the very small solute droplets formed at this concentration level. A linear response 
was obtained above about 0.2 mg/mL. The extent of the linear range was not tested. 
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System reproducibility test 
The reproducibility of the HPLC system with the ELSD connected after the UVD was 
checked by making 10 injections of 0.5 mg/mL paracetamol solution. The response of 
the UVD (A. = 265 nm) and ELSD (gas flow rate 2.0 L/min, mobile phase flow 1.0 
mL/min, drift tube temperature 95°C) are compared in Table 3.3. 
Table 3.3 Peak Areas recorded for Paracetamol (0.5 mg/mL) by the UVD and ELSD 
connected in series 
Injection number UVD Peak Area ELSD Peak Area 
1 4.425 1.184 
2 4.394 1.091 
3 4.394 1.097 
4 4.388 1.060 
5 4.403 1.001 
6 4.402 1.115 
7 4.393 1.054 
I 
8 4.394 1.162 
9 4.396 1.098 
10 4.40 0.956 
Average 4.399 1.082 
RSD (%) 0.23% 5.8% 
The relative standard deviation (RSD) of 0.23% achieved by UVD was much smaller 
than the value of 5.8% obtained for the ELSD. Since these results were obtained from the 
same injections, it is indicative that the injection process was satisfactory while the 
response of the ELSD is much more variable than that of the UVD. The reasons for this 
variation were examined in relation to the analysis of Simethicone, described in the 
following section. 
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3.2 Development of a reversed-phase HPLC method for Simethicone 
3.2.1 Analysis of Simethicone by Isocratic Elution 
The reversed-phase C8 column and isocratic elution with acetonitrile-chloroform (30:70) 
at a flow rate of 1.0 mL/min was used in an attempt to develop a simple chromatographic 
system for the analysis of PDMS. This produced a single peak for PDMS solution in 
chloroform with retention time of 4.2 min. A series of dilutions ofPDMS USP Reference 
Standard was analysed with~the results shown in Table 3.4. 
Table 3.4 Peak Areas recorded using the ELSD for PDMS (USP Reference Standard) 
solutions in chloroform 
Solution ID PDMS Peak Peak Peak Average 
Concentration Area I Area2 Area3 Peak Area 
(mg/mL) 
Ul 0.2148 0.80 0.80 0.80 0.80 ± 0.0 
U2 0.4296 1.80 1.80 1.70 1.76 ± 0.06 
U3 0.5370 2.20 2.10 2.15 2.15 ± 0.05 
U4 0.8592 3.50 3.50 3.60 3.53 ± 0.06 
us 1.074 4.50 4.40 4.50 4.43 ± 0.06 
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Fig 3.3 ELSD Peak Area for PDMS (USP Reference Standard) Solutions in Chloroform 
A good linear response with correlation coefficient of 0.99 was obtained for solutions in 
the concentration range 0.2 to 1.2 mg/mL of PDMS. The specificity of the isocratic 
HPLC assay in relation to the analysis of Simethicone in formulations was then tested in 
two ways. First, a sample of placebo matrix (containing no Simethicone) was acidified 
with HCl and extracted with chloroform. The chloroform extract was injected into the 
HPLC with the result that a peak was observed at a retention time of 3.6 min, which is 
close to that of PDMS ( 4.2 min). In the second test, an HCl solution was extracted with 
chloroform. This extract also produced a peak at short retention time overlapping with 
the PDMS peak, subsequently identified as being due to grease used on the stopcock of 
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the separating funnel. The use of an isocratic mobile phase containing of 60% 
chloroform and 40% acetonitrile extended the retention of the PDMS peak away from 
the interfering peaks but also broadened it severely. Thus interference from excipients 
and stopcock grease showed that chromatography using isocratic elution was 
unsatisfactory for the formulation samples. 
3.2.2 HPLC Analysis of Simethicone using Gradient Elution 
In order to achieve a better separation of excipients from PDMS, while maintaining good 
peak shape, a gradient elution was considered necessary. The additional objective was to 
achieve some resolution of individual oligomers of the polymeric PDMS. 
Two different varieties of PDMS were available for testing: 
1. USP Reference Standard 350 cs with a specific gravity of 0.970 and average 
molecular weight of 27000. 
2. USP Reference Standard 200 cs with an average molecular weight of 1800 
Both the USP standards were dissolved with chloroform directly and diluted to a 
concentration of2.0 mg/mL for injection into the HPLC. 
The ELSD parameters were finalised as follows using the same procedure as detailed for 
paracetamol in section 3.1. The mobile phase flow rate was 1.0 mL/min, the gas flow 
rate was set at 2.0 L/min, and the drift tube temperature was 95 °C. 
The gradient elution program shown in Table 3.5 was found to achieve a separation of 
PDMS for quantitative analysis ofPDMS. 
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Table 3.5 Gradient elution program for PDMS analysis 
Solvent A-Acetonitrile: Solvent B- Chloroform 
Time (min) Function Value 
1 T.Flow 1.0 mL/min 
B.Concentration 25% 
4 B.Concentration 25% 
5 B. Concentration 75% 
1 
25 B.Concentration 75% 
40 B. Concentration 25% 
I 
50 B. Concentration 25% 
I 
The chromatograms obtained for the separation of high viscosity and low viscosity 
PDMS are shown in Fig 3.5 and 3.6, respectively. The USP Reference Standard with 
high viscosity (high molecular weight) could only be eluted as one complex peak 
whereas the USP PDMS 200 cs was separated into its constituent oligomers. This can be 
explained on the basis of the large difference in molecular weight for the oligomers of 
the low viscosity PDMS. Individual oligomers differ by 78 Daltons, the mass of the 
(CH3)2-Si-O repeating unit. The average molecular weight of the 200 cs PDMS is about 
1800, so that each oligomer is approximately 4% different in mass and capable of being 
resolved in the HPLC system. On the other hand, the high molecular weight PDMS (as 
used in Mylanta Liquid) has an average chain of 27000 Daltons, with 0.2% difference 
between oligomers. This small difference appears to be beyond the resolution 
capabilities of the present HPLC system. 
43 
Chapter 3 Results 
1l 
15 
14 
R 
e 12· 
s 
p 1) 
0 
n 
8 
s 
e 
6-
4 
0 
0 1) :n 3l 4l Sl fJ) 
Retention Time (min) 
Fig 3.4 Separation of PDMS 350 cs (high molecular weight-high viscosity) by gradient 
elution 
44 
R 
e 
s 
p 
0 
n 
s 
e 
I A ~ 
0 5 10 
Retention Time (min) 
Chapter 3 Results 
~ 
15 al 
Fig 3.5 Separation of PDMS low viscosity 200 cs (low molecular weight) by gradient 
elution 
45 
Chapter 3 Results 
. : :m:::: :~~; :~ ~= :-~: :--:. · ,-:: •. • ~. ~ . .. .. .-, :-- ;.. __ ; • ... :· _, ... , : ·. ~--~- ~ .-:. ~·; ., .. ~·;!j,: :~!:;! :! ; i; !i i Hi : ;··;~:~~~7!; :;: ! : :;~~~~i!;H: i!i!i~i;:;i;:;!:::• :-~:-~~:.:~~~:::~ ~~; :;:: ;:;:.:.:.;;..-:-£!~:;~; ~;!i; ::1 .. >: !!:il r•!• :·~ :.-.::-...:.-= •• •.•• :: •• 1 
While the gradient elution program was not able to resolve the individual oligomers of 
the high molecular weight PDMS, it was apparent that quantification of total PDMS in 
Mylanta Liquid Suspension could be achieved in this way. To lessen the retention time, 
the gradient elution program was modified to that given in Table 3.6. The resulting 
chromatogram is shown in Fig 3.6. With the faster elution program, the resolution of 
PDMS from all the excipients was achieved and the retention time was shortened and the 
peak shape was suitable for quantification. 
Table 3.6 Modified gradient elution program and system parameters 
Time (min) Function Value 
0.01 TFlow 1.0 mL/min 
I 
5.0 B.Conc 25%B 
10.0 B.Conc 85% 
15.0 B.Conc 25% 
20.0 Stop 
HPLC conditions 
Mobile phase A: Acetonitrile B :Chloroform 
ELSD Parameters Gas flow 2.0 Llmin 
Mobile flow 1.0 mL/min 
Attenuation 1 
Drift tube temperature 95°C 
Output attenuation 11 
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In order to validate the assay procedure, a series of tests were performed to determine the 
system reproducibility and precision. 
3.2.3 System precision and reproducibility 
Since the detection principle of the ELSD involves nebulization of the column effluent to 
form an aerosol, the nebulization process is the key to obtaining satisfactory 
reproducibility and precision. 
Ten injections of 0.21 mg/mL PDMS USP reference standard solution were made with 
the HPLC-ELSD system operating with the gradient elution program in Table 3.6. 
The retention time and peak area for each injection are reported in Table 3. 7. 
Table 3.7 System precision test using USP Reference PDMS (0.21 mg/mL) 
Injection Number Retention Time (min) Peak Area * E6 
1 9.33 6.87 
2 9.34 7.59 
3 9.36 5.96 
4 9.34 6.56 
5 9.34 7.38 
6 9.34 6.89 ! 
7 9.33 6.49 
8 9.33 7.17 
9 9.35 6.43 
10 9.33 7.02 
Average 9.34 6.84 
SD 0.009 0.49 
RSD% 0.10% 7.2% 
P A *E6 = Integrated Peak Area (in arbitrary units) x I 0 
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While the retention time of the peak was reproducible to 0.1 %, the peak area variation qf 
approximately 7% was considered unacceptable. From the results obtained with 
paracetamol using the UVD in series with the ELSD, it was clear that the large variation 
in peak area was due to the ELSD and not the HPLC system. Different ways were 
explored to improve the system precision, including washing the complete system 
thoroughly, and testing the precision of another ELSD on loan from Alltech Associates. 
Different solutes, such as caffeine, paracetamol and USP Reference 
polydimethylsiloxane, were examined, but there was no significant difference in the 
relative standard deviation between detectors and samples. 
A build-up of retained sample in the drift tube and nebulizer is a possible cause of the 
variation of response of the ELSD. Cleaning the drift tube and nebulizer at frequent 
intervals was found to improve the reproducibility. Premature evaporation of the solvent 
will lead to blockage ofthe very fine needle of the nebulizer, as well as material adhering 
to the inner surface of the drift tube, thereby affecting the precision and reproducibility. A 
routine clean up procedure was established by soaking the drift tube in chloroform for 2 
hours, followed by washing with methanol, this procedure was carried out once every 2 
weeks and the system precision was improved to about 4%, as shown in Table 3.8. 
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Table 3.8 HPLC-ELSD System precision using PDMS (0.4228 mg/mL) after cleaning 
the drift tube and nebulizer 
Injection No Retention time (min) Peak Area*E6 
1 9.32 11.34 
2 9.34 10.86 
3 . 9.36 10.24 
4 9.39 10.21 
5 9.35 11.54 
I 
6 9.34 10.62 
I 
7 9.34 10.71 
8 9.34 11.13 
9 9.34 10.56 
10 9.30 11.17 
Average 9.34 10.84 
SD 0.023 0.45 
RSD 0.25% 4.2% 
Another important factor, in terms of reproducible operation of the ELSD is the nitrogen 
gas flow to the nebulizer. A varying gas flow rate to the ELSD will cause the size of the 
sample droplets to change leading to a variation in response. The gas flow controller was 
found to be leaking and was replaced. The system precision was checked again with the 
results shown in Table 3.9, indicating an improved precision of 2.6% RSD. 
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Table 3.9 PDMS System precision test after changing the flow controller (PDMS 
solution of0.21 mg/mL) 
Injection No Retention time (min) Peak Area*E6 
1 9.34 7.10 
2 9.34 7.46 
3 9.35 7.12 
4 9.35 7.53 
5 9.35 7.30 
6 9.34 7.56 
7 9.35 7.33 
8 9.35 7.57 
9 9.34 7.57 
10 9.35 7.20 
Average 9.35 7.38 
SD 0.003 0.19 
RSD 0.04% 2.6% 
Repeated experiments showed that an expectation of about 3% RSD is achievable for 
PDMS detection by the ELSD. This was confirmed by an independent experiment, 
carried out by the detector manufacturers, Alltech Associates. 
It was found that by continuous monitoring and manual adjustment of the gas flow rate 
for every injection, the RSD could be reduced to about 1.5%. Since this requirement is 
contrary to the concept of an· automated analytical procedure for batch analysis, the 
instrument manufacturer was notified. Newer models of the ELSD from Alltech 
Associates are reported to have incorporated a gas flow controller with improved 
characteristics. 
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The precision of the HPLC system was also checked by making six injections of USP 
PDMS reference standard solution on each of the six different days. The peak area and 
retention time recorded as shown in Table 3.10. The purpose of the precision test is to 
determine the intraday and interday variations of the equipment parameters, such as 
injection volume, mobile phase flow rate and nitrogen gas flow to the ELSD. 
Table 3.10 System precision test (USP PDMS in chloroform) 
PDMS 0.432 mg/mL PDMS 0.434 mg/mL PDMS 0.40 mg/mL 
(31 /8/99) ( 4/8/99) (31/8/99) 
ID Peak Retention ID Peak Retention ID Peak Retention 
Area Time Area Time Area Time 
*E6 (min) *E6 (min) *E6 (min) 
1 4.08 9.28 1 3.57 9.26 1 2.71 9.00 
2 3.77 9.26 2 3.38 9.27 2 2.57 9.02 
3 3.90 9.26 3 3.73 9.27 3 2.73 9.01 
4 3.90 9.26 4 3.63 9.28 4 2.78 9.02 
5 3.75 9.26 5 3.46 9.28 5 2.69 9.01 
6 3.73 9.26 6 3.48 9.26 6 2.69 9.01 
Ave 3.86 9.26 Ave 3.54 9.27 Ave 2.70 9.01 
SD 0.13 0.008 SD 0.13 0.009 SD 0.07 0.008 
RSI 3.5% 0.09% RSD 3.6% 0.10% RSI 2.6% 0.08% 
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Table 3.11 System precision test (inter-day) 
PDMS 0 .40 rng/mL PDMS 1.2 mg/mL PDMS 1.73 mg/mL 
(3/9/99) (29/9/99) (21/10/99) 
ID Peak Retentio ID Peak Retention ID Peak Retenti01 
Area Time Area Time Area Time 
*E6 (min) *E6 (min) *E6 (min) 
I 
1 2.71 9.0 I 8.22 9.32 I 19.09 9.16 
2 2.57 9.02 2 8.31 9.32 2 19.60 9.16 
3 2.73 9.0I 3 8.28 9.31 3 19.66 9.16 
4 2.78 9.02 4 7.74 9.31 4 19.15 9.16 
5 2.61 9.01 5 8.17 9.32 5 18.98 9.15 
6 2.69 9.01 6 8.19 9.31 6 19.32 9.15 
Ave 2.68 9.01 Ave 8.15 9.32 Ave 19.30 9.16 
SD 0.08 0.007 SD 0.21 0.005 SD 0.28 0.005 
RSD 3.0% 0.08% RSD 2.6% 0.06% RSD 1.4% 0.06% 
From replicate injections, the RSD of the peak area varied between 2% and 4% thereby 
suggesting that the acceptance criteria for this measurement should be 3%. The retention 
time RSD was consistently within 0.1 %. The acceptance criteria of < 0.5% was adopted for 
the retention time variation. The HPLC- ELSD system was considered to be suitable for the 
development of the Simethicone analysis with these acceptance criteria. 
An alternative approach, to provide an analytical procedure that would take account of 
small variations of the gas flow and other parameters, is the use of an internal standard. A 
number of possible materials for use as internal standard have been investigated, such as 
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long chain and cyclic hydrocarbons (tetradecane, octadecane, hexadecane, anthracene, 
etc), but no suitable substances have been identified due to their elution at the same 
retention time as the excipients from Mylanta formulation. Thus the Simethicone assay 
development was attempted on the basis of obtaining a reproducible extraction of the 
PDMS from the antacid formulation, together with a closely monitored operation of the 
ELSD. The acceptance criterion for the instrument precision was set at 3%. For each 
batch of samples that were analysed by the HPLC-ELSD system, an instrument precision 
test was run and results of'this were required to meet the acceptance criterion. 
3.3. PDMS content of Simethicone 30% Emulsion 
The first step in developing the assay method was to determine the PDMS content of the 
Simethicone 30% Emulsion used as the raw material in the antacid formulation. The 
Emulsion was acidified and the PDMS was extracted with dichloromethane. The 
separation of PDMS from the other components extracted from Simethicone Emulsion is 
shown in Figure 3.7. The peak with retention time of 9.35 minutes was identified in 
shape and retention time as that obtained with the PDMS standard. The peak at 3.2 
minutes can be attributed to other components of Simethicone Emulsion such as 
emulsifiers that are also extracted under these conditions. 
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Fig 3. 7 HPLC chromatogram of Simethicone Emulsion Extract in chloroform 
A standard curve was generated by measuring the peak area for a series of solutions of 
PDMS USP Reference Standard in chloroform, as given in Table 3.12 and Figure 3.8. 
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Table 3.12 Peak Areas for the PDMS USP Reference Solutions 
USP reference standard Average peak area*E6 Standard deviation 
concentration (mg/mL) 
0.251 1.93 0.09 
0.502 4.06 0.08 
1.004 7.62 0.19 
1.506 11.39 0.31 
2.008 16.39 0.67 
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Figure 3.8 USP reference PDMS standard curve- Peak Area * E6 versus concentration. 
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3.3.1 Extraction Efficiency Test 
PDMS Recovery 
In order to study the effect of extraction of the analyte, recovery is computed by 
comparing responses of replicates of extracted samples with those of extracted blank 
matrix to which analyte has been added at the same nominal concentration. Although it is 
desirable that recovery has to be the highest possible, it is not necessary to achieve 
complete recovery to prm;ide good accuracy and precision, if adequate reproducibility can 
be attained. USP reference standard PDMS sample ( 40 mg) was weighed and dissolved in 
dichloromethane, hydrochloric acid (15 mL) was added, then the procedure was followed 
as in section 2.3. The percentage recovery ofPDMS was calculated. 
Table 3.13 PDMS USP reference standard curve for Extraction Efficiency Study 
Concentration of Average Peak SD 
PDMS Area *E6 
(mg/mL) 
0.16 1.10 0.15 
0.40 2.76 0.21 
0.80 5.69 0.65 
1.20 8.72 0.51 
1.60 11.17 0.74 
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Figure 3.9 USP reference PDMS standard curve for Extraction Efficiency Study 
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Table 3.14 Analysis ofUSP PDMS extraction samples (three extractions) 
ID Weight Average Total PDMS %Recovery 
PDMS (mg) Peak Area*E6 Determined (mg) 
UEI 38.3 11.8 ± 0.26 37.86 98.9 
UE2 40.8 11.9 ± 0.77 38.19 93.6 
UE3 40.0 12.31 ± 0.59 39.51 98.8 
UE4 41.8 12.7 ± 0.13 40.81 97.6 
UES 42.1 12.74 ± 0.30 40.93 97.2 
UE6 41.5 12.97 ± 0.01 41.66 100.4 
Average 97.8 
RSD 2.5% 
The results indicated that the three-extraction procedure gave almost complete extraction 
of PDMS from the aqueous layer, the recovery was 97.8 ± 2.5% (average of six 
determinations). Given the magnitude of the instrument precision, this figure is not 
significantly different from 100%. Nevertheless, the 97.8 ± 2.5% recovery figure was 
applied in subsequent calculations. 
Two to four extractions of the Simethicone Emulsion samples were performed and the 
samples were analysed in order to find out how many extractions were necessary to get a 
complete extraction of PDMS from the formulations. 
Sixteen samples of 1.5 gram of Simethicone Emulsion were weighed out into separation 
funnels individually, five of them were extracted twice, five were extracted four times and 
the remaining six were extracted three times. The reconstituted sample solutions were 
analysed against the PDMS USP reference standard curve, and the percentage of PDMS 
in the Simethicone Emulsion was calculated. 
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Table 3.15 Analysis ofPDMS in Simethicone Emulsion (2 extractions) 
ID Simethicone emulsion %PDMS 
Amount taken (g) Found 
S1 1.5056 25.38 
S2 1.5080 25.11 
S3 1.5067 23 .92 
S4 . 1.5095 26.86 
S5 1.5062 25.29 
Average 25.90 
RSD 4.2% 
Table 3.16 Analysis ofPDMS in Simethicone emulsion (3 extractions) 
ID Simethicone taken Total PDMS Found %PDMS 
(mg) (mg) 
Sl 133.1 34.77 26.72 
S2 133.9 35.95 27.47 
S3 133.4 34.26 26.28 
S4 133.9 34.68 26.50 
S5 133.5 34.57 26.49 
S6 133.9 35.34 27.00 
Ave 34.93 26.74 
SD 0.60 0.43 
RSD 1.6% 1.6% 
-----------~ ~- -----
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Table 3.17 Analysis ofPDMS in Simethicone Emulsion (4 extractions) 
ID Simethicone emulsion % PDMS 
Amount taken (g) Found 
S1 1.5058 24.37 
S2 1.5025 27.01 
S3 
' 
1.5077 25.16 
I 
S4 1.5037 26.99 
I 
ss 1.5072 26.67 I 
Average 1.5054 26.04 
RSD 4.1% 
-
In summary, Simethicone Emulsion that had undergone two, three and four extractions 
gave a PDMS content of 25.9, 26.7 and 26.0%. No significant difference in the PDMS 
content of the Simethicone Emulsion between the procedures involving two, three or 
four extractions could be seen. Hence, in subsequent work the samples were prepared 
using three extractions. 
In a further determination of the reproducibility of the assay for PDMS in Simethicone 
Emulsion, six more samples of Simethicone Emulsion were prepared with 3 extractions 
and analysed. 
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Table 3.18 USP PDMS Standard Curve for Simethicone Emulsion Assay 
ID USP Reference PDMS Average Peak Area*E6 SD 
Concentration (mg/mL) 
Ul1 0.41 2.94 0.05 
Ul2 0.41 3.37 0.05 
U21 0.81 6.51 0.05 
U22 0.81 6.75 0.49 
U31 1.22 9.57 0.33 
U32 1.22 10.40 0.11 
U41 1.62 13.02 0.47 
U42 1.63 13.34 0.33 
U51 2.03 15.63 0.10 
U52 2.03 16.38 0.27 
Table 3.19 Analysis ofPDMS in Simethicone Emulsion (Reproducibility Study) 
ID Simethicone PDMS Found (mg) PDMS content% 
Emulsion taken 
(mg) I 
S1 133.9 36.45 27.85 
I 
S2 133.5 35.63 27.31 I 
S3 134.0 36.22 27.65 
S4 133.2 35.01 26.89 
ss 133.7 35.91 27.48 
S6 134.4 36.67 27.91 
Ave 27.51 
SD 0.38 
RSD 1.4% 
- · ·-
. . 
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Combining the results of the assays using three extractions, the analysis of Simethicone 
Emulsion (Batch Number HH077242) gave the average PDMS content of (27.1 ± 0.4)%. 
Individual assays had a RSD of 1.4 to 2.8%, ie, within the acceptance criteria. The 
Certificate of Analysis from the manufacturer (Dow Corning Company) for this batch of 
Simethicone Emulsion gave a PDMS content of28.5% as determined by the USP method 
(infrared analysis). The RSD is not stated on the Certificate of Analysis, but it would 
need to be about 5% (ie, ± 1.4) in order that the value recorded here by the HPLC method 
is not significantly different. The specification limits for PDMS content of Simethicone 
Emulsion are given on the Certificate of Analysis as low 27.8, high 31.6, but this is not 
necessarily indicative of the RSD for the USP analysis. 
3.4. PDMS content of Mylanta Liquid Suspension 
3.4.1 Separation of PDMS from Mylanta Liquid Suspension 
The basis of the assay of the Simethicone content of the Mylanta Liquid Suspension was 
to construct a recovery standard curve by assaying known amounts of Simethicone 
Emulsion added to Mylanta Placebo Matrix. This was done by taking approximately 67, 
100, 133, 167 and 200 mg of the Simethicone Emulsion and mixing with 10 g Placebo 
Matrix, representing 50, 75, 100, 125 and 150% of the nominal Simethicone Emulsion 
content of the formulation. After extraction (3-fold) the solution were analysed by the 
HPLC-ELSD system. The peak areas obtained were the average of three injections. 
Approximately 10 mL of Mylanta Liquid Suspension was extracted the same way. A 
typical chromatogram is shown in Fig 3.10. 
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Figure 3.10 Separation of PDMS in the Extract from Mylanta Antacid Suspension 
Mylanta Assay 
In the procedure, six replicate aliquots from the same composite sample of Mylanta 
Liquid Suspension were extracted and assayed according to the gradient elution program. 
The same batch of Simethicone Emulsion was used throughout this project for standard 
curves, and Mylanta Liquid Suspension (Batch number MPOIC - prepared 30/3/99 -
stored at 40°C) was used for purposes of validation of the assay. Then the assay results 
for different batches ofMylanta Liquid Suspension were compared. 
64 
- - - - - - - -
Chapter 3 Results 
:·:' ·:::;!; . =~; ;~:,,: :, :;-:·· ;.-; ~:::; i: -~ :.:- .... . ; -;:;. :ii ~~,! = !::.-;;=;: : :~;, ,;,,, , ~;~,~- :=. • :;~~;::,,~:!:!ld:·;•.•:;~ ;~~~!~EJ~•!i~t;:;·.,;;.-~;;~~!l!::::r..~;~-'?~:.::~;.::;:~:;:.:.:,.-~;:::•;;;~i': ti7:=·~···:;.; :(i;.-;:; •;: , i~;~~~:'~~: .. l; !:i:c~:!:"::, :; ~n;l=}!:::,::i<:.:..J~ .. 
Table 3.20 Simethicone Recovery Standard Curve 4/8/99 
ID Simethicone Peak Area Peak Area Peak Area Average SD 
Emulsion I *E6 2 *E6 3 *E6 Peak Area 
(mg) *E6 
' 
I 
R1 67.7 5.51 5.39 5.64 5.52 0.13 
J 
R21 99.6 8.41 8.11 8.51 8.34 0.20 
I 
R22 100.7 8.26 8.21 8.75 8.41 0.27 
R31 133.9 11 .03 11 .69 10.98 11.23 0.36 
R32 133.9 11.57 11.93 11.06 11.52 0.44 
R41 167.1 13.81 13.33 13.49 13.54 0.11 
R51 201.5 17.87 17.14 17.13 17.38 0.14 
R52 201.4 17.62 16.75 17.16 17.18 0.24 
- - - - · --
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Figure 3.11 Simethicone Recovery Standard Curve 4/8/99 
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Table 3.21 Analysis ofMylanta Liquid Suspension B#MPOIC 
(Manufactured 30/3/99- stored at 40°C - Specific gravity 1.08) 
ID Mylanta Liquid Average Peak Area * E6 Simethicone I 
Emulsion taken (g) content (mg/lOmL~ 
MEl 10.0632 9.8859 36.08 
I 
ME2 10.0711 10.5572 36.60 
ME3 10.0883 10.224 36.37 
ME4 10.0795 10.4226 36.99 
ME5 10.0890 10.6473 37.47 
ME6 10.0824 10.1596 37.16 
Average 36.78 
SD 0.48 
RSD 1.3% 
The average content of 36.8 ± 0.5 mg Simethicone in 10 mL of Mylanta Liquid is 
significantly lower than the label figure of 40 mg/1 0 mL. While the intra-batch precision 
is very good at 1.3%, there are a number of factors that may be different when the batch 
is assayed again, eg, the mixing of the formulation. Therefore it is important to validate 
the assay procedure by a series of determinations on different days, to ensure that it is 
capable of a precision whereby the discrepancy of the content as shown here is 
verifiable. 
3.4.2 Validation of the assay method 
The ultimate goal of the method validation process is to provide evidence that the method 
does what it is intended to do (Bressolle et al, 1996). All of the variables of the method 
should be considered, including sampling procedure, sample preparation, 
chromatographic separation, detection and data evaluation and the use of the sample 
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matrix as that of the intended samples. The extent to which these variables affect the 
assay result is found by repeating the full procedure several times on different days. 
The validation of the analytical method includes an examination of the selectivity, method 
precision, reproducibility, linearity, recovery, solution ruggedness, and where appropriate, 
membrane binding in a filtration step. 
3.4.2.1 Selectivity 
The term selectivity and specificity are often used interchangeably in relation to an 
analytical procedure. Specificity is the ability to assess unequivocally the analyte in the 
presence of endogenous compounds. Selectivity includes the ability to separate the 
analyte from degradation products, metabolites and other components of the formulation. 
The simplest test to validate the selectivity for chromatographic analysis was to 
demonstrate a lack of response in the blank sample matrix. In this project, the retention 
time of endogenous components of the matrix was compared to that ofPDMS. 
A 1 0 mL sample of the placebo matrix was analysed according to the method with 3 
extractions. No peaks were detected with retention time between 7 and 12 minutes in the 
region corresponding to PDMS, confirming that there is no interference from excipients 
or reagents (Fig 3.12). 
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Figure 3.12 Blank Chromatogram of extract of placebo matrix 
3.4.2.2 Method precision 
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Hl 
Precision is usually assessed on a within-batch and a between-batch basis. Between-batch 
assessment is not always carried out with a single batch per day, and some batches may be 
of sufficient size that more than one day is required for analysis. 
The accuracy and precision should be determined with a minimum of five determinations 
per sample (excluding blank sample matrix) from an equivalent biological matrix. The 
precision around the mean value should not exceed 15% and the mean value should be 
within ± 15% deviation of the nominal value, ie, the bias should be less than 15% for 
acceptable accuracy (Hartmann et al, 1997). 
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In order to validate the method and check the method precision, the same batch ofMylanta 
Antacid Suspension was re-assayed twice, with the results shown in Table 3.22. For each 
set, this included the full preparation of the recovery standard curve using Simethicone 
Emulsion and Placebo matrix. 
Table 3.22 Method precision test results 
10 Mylanta Suspension taken (mg) Simethicone Content 
. (mg/10 mL) 
Test 1 Equation of the recovery standard curve: Y = 0.069X- 0.808, RL = 0.99 
MEl 10.0399 38.6 
ME2 10.0743 39.9 
ME3 10.0177 36.5 
ME4 10.3560 36.8 
ME5 10.0733 36.2 
ME6 10.4234 36.9 
Average 37.5 
so 1.4 
RSO 3.8% 
Test 2 Equation of the recovery standard curve: Y = 0.065X + 1.461, Rl = 0.99 
MEl 10.0287 37.0 
ME2 10.0566 34.7 
ME3 10.0990 35.8 
ME4 10.0430 37.0 
ME5 10.0830 35.5 
ME6 10.0819 37.4 
Average 36.3 
so 1.0 
RSD 2.9% 
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From Tables 3.21 and 3.22 three complete assays of the same batch of Mylanta Liquid 
Suspension gave the Simethicone content of 36.8, 37.5 and 36.3 mg/1 0 mL, with the RSD 
varying from 1.3 to 3.8%. It can be concluded that the precision of the assay is 4%. 
3.4.2.3 Linearity and working range 
It is necessary to use a sufficient number of standards to define adequately the relationship 
between concentration and response. Although some analytical procedures may require the 
use of non-linear calibration, it is customary to use a linear model, with the standard 
parameter estimation procedure based on the "least squares" methodology. In this 
approach, the independent variable (x) is concentration, the dependent variable (y) is the 
instrument response, and the computation procedure implicitly assumes that the 
measurement error is the same and normally distributed for each sample (y). 
Linearity of the method was demonstrated by showing that the slope of the linear 
calibration curve is statistically different from 0, the intercept is not statistically different 
from 0 and that the regression coefficient is not statistically different from 1. 
In the assay development, two types of calibration curve are required. The first is the 
PDMS standard curve for the PDMS content of Simethicone Emulsion, and the second is 
the Simethicone Recovery standard curve for the Simethicone content of Mylanta 
Suspension. The PDMS Standard curves for the Simethicone Emulsion assays reported 
above were linear in the PDMS concentration range 0.4 to 2.0 mg/mL 
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Table 3.23 Equation parameters for PDMS standard curves 
Date and Test Correlation Slope Y -intercept 
Coefficient 
23/4/99 Simethicone Emulsion assay 0.999 8.627 0.582 
2/7/99 Simethicone Emulsion assay 0.997 6.701 0.173 
10/8/99 Simethicone Emulsion assay 0.998 7.551 0.182 
23/8/99 Simethicone Emulsion assay 0.997 7.953 0.096 
The correlation coefficient was always better than 0.996, so the acceptance criteria of 
< 0.996 was established for the PDMS standard curve. 
In the Mylanta Suspension assay, the standard curves for Simethicone recovery were linear 
in the concentration range of 50 to 150 nominal % content for Simethicone Emulsion in 
Mylanta Suspension. From the results in Table 3.24, in the range of 50 to 150% of the 
nominal Simethicone content of the sample, the slope was linear. 
Table 3.24 Equation Parameters for Simethicone Recovery Standard curve 
Date and Test Correlation Slope Y -intercept 
Coefficient 
4/8/99 Recovery standard curve 0.998 0.087 -0.338 
3/9/99 Recovery standard curve 0.998 0.071 -0.894 
15/11199 Recovery standard curve 0.996 0.065 1.461 
On the basis of the parameters in Table 3.24, the acceptance criteria of the correlation 
coefficient was set at < 0.995. 
72 
Chapter 3 Results 
. ·.·.:·.::;!;;.;;; .•••• :=:~: ,:.··.· . :.·:!:':: :·.:;: ::;; ;=:=:·:~::l;i·!:!~:~;·:·: ::!··~ i!!: :··; :~":!;:~i!;p;;;~;=: =:::i:~· .:.: .•. ;~;:;:. : . ::i'; :;::; : . ' ;··.:·;:· ;.:; ==! :•;:. :·-~· !; . :: •• 1; ~j: ! : ; : :, . ··.: ; :-: · : ; ; ! : : :' : • , • 1 ' \ ~ 
3.4.2.4 Ruggedness of the Method 
The ruggedness of the method can be assessed by studying the eventual effect of different 
sets of conditions on the method. This is done through cross-validation. Typical reasons 
for cross-validation should include transfer of the method from one analyst to another, 
significant instrumental or procedural modification (in HPLC, the difference in 
chromatographic performance between columns of the same designation is the most 
, 
common source of chromatographic variability) and a significant time lapse between 
periods of operation. In this project, it was not possible to test the effect of different 
analysts, instrumentation or laboratories, but one important ruggedness factor related to 
the stability of the samples once prepared. In the normal conduct of the assay, the 
reconstituted extracts of PDMS were subjected to the HPLC analysis as soon as each 
batch was ready. Each batch consisted of2 solvent blanks, 2 PDMS reference solutions, 6 
Simethicone recovery standards and 6 Mylanta extracts, a total of 16 samples. As each 
sample was injected 3 times, the total elapsed time for the batch analysis was about 24 
hours. Since the samples contained the volatile solvent chloroform, it was important to 
establish that the samples were stable for that length of time, and also to determine if they 
could be stored in circumstances when the HPLC instrumentation was not available for 
immediate analysis. This was checked as follows. 
Test 1 PDMS Standard solution stability 
The stability of PDMS standard solution was based on triplicate determination of PDMS 
samples at three concentration levels (low, medium and high) at multiple time points 
after the start of storage to allow "trends" to be detected. The issue is not whether there is 
a trend in degradation, but whether the study samples are adequately preserved at the 
time of analysis. 
Separate sealed vials ofPDMS solutions in chloroform were stored at 4°C for 0, 24, 48, 
72, 96 hours and then examined by the HPLC procedure. 
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Table 3.25 Standard PDMS solution stability 
Sample used: USP reference standard PDMS solution 1.2 mg/mL 
ID Oh 24 h 48 h 72 h 96h 
1 8.22 7.56 8.17 7.66 8.26 
2 8.31 8.26 7.86 7.89 8.29 
3 8.28 8.11 8.24 8.21 8.76 
I 
4 7.74 7.84 7.95 8.19 8.66 
I 
' 
5 8.17 7.79 8.47 7.93 7.98 
6 8.19 8.09 8.04 8.12 8.14 
7 8.27 7.77 8.04 7.95 8.38 
8 8.45 8.30 8.45 8.06 7.90 
9 8.23 8.24 7.86 8.47 8.18 
10 8.33 8.08 8.22 8.52 8.11 
Ave 8.22 8.00 8.13 8.10 8.27 
SD 0.19 0.25 0.22 0.26 0.27 
Deviation from initial value 0 -2.7% -1.6% -1.5% +0.6% 
The variation in the peak area for PDMS in chloroform solution was in all cases less than 
3%, ie, within the acceptance criteria for the system precision. Hence it can be concluded 
that the PDMS solution in chloroform was stable over 96 hours of this experiment. Similar 
results were gained for other concentrations tested. 
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Test 2 - Stability test of Mylanta Emulsion Extract samples (Performed on 4/9/99) 
The samples were prepared for the complete assay (Simethicone recovery standards and 
Mylanta Suspension extracts). Each reconstituted solution was subdivided into two HPLC 
vials, one set of which were analysed immediately, while the other was stored at 4°C for 
24 hours and then analysed. The result of the immediate analysis is given in Table 3.21 as 
part of the method precision test, and the result for the 24 hour stored samples is shown in 
Table 3.26. 
Table 3.26 24 Hour stability results of Mylanta Extracts 
ID Mylanta Suspension taken Sirnethicone Content 
(g) Found 
(mg/10 mL) 
MEl 10.0399 36.28 
ME2 10.0743 37.73 
ME3 10.0177 34.67 
ME4 10.3560 36.23 
MES 10.0733 35.63 
ME6 10.4234 36.19 
Average 36.1 
SD 1.0 
RSD 2.8% 
The reconstituted samples assayed twenty-four hours after preparation gave a Simethicone 
content of 36.1 ± 1.0 mg/1 0 mL, compared to the value of 36.8 ± 0.5 mg/1 0 mL when 
assayed immediately (Table 3.21). The difference of 0.7 represents a 2% variation, which 
is well within the method precision of 4%. Additionally, the difference is not significant 
according to the Student's t-test based on the RSD of the data sets. 
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3.4.2.5 Membrane binding test 
Since the sample preparation procedure involved a filtration step, it is possible that some 
of the PDMS could adhere to the filter membrane and housing. In order to test if binding 
occurred, a PDMS solution in chloroform was analysed before and after filtering. The USP 
Reference Standard PDMS solution was prepared and two aliquots were filtered through 
two different 0.45 ~m filters (polypropylene housing-PTFE membranes and Millex 
. 
membrane). The filtered and unfiltered samples were analysed (Table 3.25). 
Table 3.27 Effect of filtering on PDMS Content 
Sample used : PDMS 0.960 mg/mL in chloroform 
ID Peak Area- Peak Area- PTFE Peak Area - Mill ex 
unfiltered filtered filtered 
1 4.62 4.84 4.69 
2 4.80 4.81 4.83 
3 4.63 4.90 4.79 
4 4.74 4.70 4.72 
5 4.73 4.56 4.59 
6 4.63 4.72 4.79 
Average 4.69 4.76 4.73 
SD 0.07 0.12 0.09 
Difference % 0 +1.5 +0.9 
The solution concentration was not affected by filtering through the PTFE or Nylon 
(Millex) membranes. The difference between the filtered and unfiltered solutions was 
within the instrument precision acceptance criteria(~ 3%). Thus it can be concluded that 
there is no significant loss of PDMS during the filtration step. 
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Stability of Mylanta Antacid Suspension 
In the assay validation it was found that the Simethicone content of one batch of Mylanta 
Antacid Suspension was 36.1 mg/1 0 mL, ie, lower than the label claim of 40 mg/1 0 mL. 
Thus several different batches of Mylanta Antacid Suspension were analysed and the 
results are shown in Table 3.28. 
Table 3.28 Analysis of Mylanta Antacid Suspension- Batches D, F and J 
ID Mylanta Antacid Average Specific Simethicone Average RSD 
Suspension Peak Gravity Content (mg/10ml 
Taken (g) Area*E6 (mg) 
Equation of the recovery standard curve: Y = 0.066X + 0.86, R2 = 0.99 
D D1 10.0521 8.4 1.081 41.85 42.02 1.9% 
D2 10.0368 8.6 1.081 42.89 
D3 10.0272 8.28 1.081 41.34 
Equation of recovery standard curve: Y = 0.066x + 0.86, RL = 0.99 
F F1 10.0358 9.17 1.082 36.57 38.69 2.8% 
F2 10.0427 9.53 1.082 38.15 
F3 10.0308 9.64 1.082 38.67 
Equation of the recovery standard curve: Y = 0.064X + 0.04 
N Nl 10.23 8.75 1.083 38.91 
N2 10.24 9.02 1.083 40.06 39.21 1.89o/c 
N3 10.25 8.72 1.083 38.68 
--
The above batches of the formulation were all stored at the same temperature (5°C) but for 
different storage times as shown in Table 3.29. 
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Table 3.29 Storage conditions ofMylanta Antacid Suspension 
Batch Number Storage condition Storage Time Simethicone content 
determined (mg/10 mL) 
N soc 2 months 39.S 
D soc 22 months 42.0 
F soc 22 months 38.7 
L_ 
·-- - -- · - - - -
' From Table 3.29 it can be seen that the variation of Simethicone content of Mylanta 
Suspension stored at S°C is greater than the assay precision, so it is a measure of the 
batch-to-batch content variation. 
Several batches that had been stored at elevated temperatures were analysed and the 
results are shown in Table 3.30. 
Table 3.30 Analysis of different batches (A, B, M) of Mylanta Antacid Suspension 
ID Mylanta Liquid Average Peak Average SD RSD 
Suspension Area *E6 Content of 
taken (g) Simethicone 
(mg/10 mL) 
Equation: Y = O.OS8X + 0.07, R2 = 0.99 
AI 10.0392 7.07 
A2 10.0170 7.92 32.41 0.87 2.7% 
A3 10.01S5 7.6S 
I 
B1 10.0046 6.84 
B2 10.1431 7.11 34.71 0.44 1.3% 
B3 10.0103 6.88 
M1 10.0770 7.02 
M2 10.0192 6.89 34.S8 0.27 0.78% 
M3 10.0592 6.91 
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Table 3.31 Analysis of different batches (E, G, H) ofMylanta Liquid Suspension 
ID Mylanta Liquic Average Peak Average Simethicon( SD RSD 
Suspension Area *E6 Content of PDMS 
taken (g) (mg/10 mL) 
I 
Equation of the recovery standard curve: Y = 0.066X + 0.86, R2 = 0.99 
El 10.02S6 9.S9 
E2 10.0164 9.51 39.52 0.64 1.6% 
• 
E3 10.0472 9.78 
Gl 10.0651 7.36 
G2 10.1107 7.S8 29.59 0.40 1.4% 
G3 10.08S6 7.47 
HI 10.0S38 8.00 
H2 10.087 8.10 32.77 0.74 2.3% 
H3 10.0462 8.36 
Table 3.32 Storage conditions of Mylanta Antacid Emulsion 
Batch Storage time Storage Simethicone content 
Number (months) condition Determined (mg/lOmL) 
N 2 soc 39.20 
I 
F 22 soc 38.69 
D 22 soc 42.02 ! 
E 4.S 30°C/60%RH 39.52 I 
A 22 30°CI60%RH 32.41 
I 
H 22 30°C/60%RH 32.77 I 
i 
B 4.5 40°C/75%RH 34.71 I 
c 22 40°C 31.S9 
G 22 40°C 29.S9 
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The formulations were also analysed by the USP FTIR method in the manufacturer's 
laboratory. The results from the two methods are compared in Table 3.35. 
Table 3.33 Comparison of batch analysis results of HPLC and IR methods. 
Batch Storage Simethicone content (mg/10 mL) %Agreement 
ID conditions 
HPLC IR 
• 
AI 30°C/60%RH 32.5 35.3 92.1 
Bl 40°C 37.2 38.0 97.9 
Cl 30°C/60%RH 32.3 34.0 95.0 
Dl 40°C 33.6 33.7 99.7 
El 40°C/75%RH 37.5 37.8 99.2 
Fl 40°C 28.1 30.4 92.4 
Gl 30°C/60%RH 36.3 38.3 94.8 
---
The comparison of the results indicated that the HPLC analysis of Simethicone in 
Mylanta Antacid Suspension was generally lower than the USP IR method but within 
the range of 90 -1 00% agreement. The differences appear to be within the precision of 
each method. Thus it can be concluded that there is a reduction of the Simethicone 
content with storage at the elevated temperatures of 30 and 40°C that is highly 
significant after 22 months of storage. 
The chromatograms of the extracts obtained from different batches were compared, and 
a slight difference of the shape of the PDMS peak was observed from the older batches 
stored at higher temperature compared to the fresher batches. The chromatogram of the 
oldest sample stored at 40°C is shown in Fig 3.13 and when compared to the 
chromatogram in Fig 3.10, it can be seen to have a broader front section and some 
splitting of the peak. If the polymeric substance degrades with chain scission, there 
would be a change in the molecular weight distribution, and that presumably would 
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change the pattern of affinity of the molecules in the HPLC column. Thus, in principle, 
the HPLC method could be used as a stability-indicating assay. Expansion of the 
solvent elution gradient was not able to achieve anything more than a broadening of the 
overall peak. 
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Fig 3.13 Chromatogram of Batch G ofMylanta Antacid Suspension 
(stored at 40°C for 22 Months) 
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An attempt was made to degrade the PDMS by ultrasonic irradiation. Simethicone 
samples were left in an ultrasonic bath for periods between 5 to 60 minutes, and then the 
chromatograms were compared. No difference could be detected. Another attempt to 
degrade the sample by physical means was by vigorously mixing the formulation for 5, 
10 and 15 minutes when preparing the sample, as mixing and shear stress may cause the 
degradation, but no effect could be observed from the chromatogram. 
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Chapter 4 Discussion 
Simethicone is a complex mixture of polydimethylsiloxane oligomers with silicon 
dioxide. It is used as an ingredient of a number of pharmaceutical formulations, in 
particular those designed for the relief of indigestion and heartburn. Because of the 
complexity of Simethicone, and its lack of easily used analytical characteristics, the 
analysis of this component has not been well developed. UV detection is not possible 
due to its lack of an appropriate chromophore. The IR method given in the USP appears 
to provide an adequate quantitation procedure for the PDMS content, but the 
interferences caused by matrix components are highly variable, and the handling of 
small volume IR cells with extremely volatile solvents require great care. Hence the 
method is not robust, nor does it have the characteristics that could be used for stability 
indication. The only chromatography method reported to date is based on gel permeation 
and utilizes a refractive index detector that has poor sensitivity, and is solvent gradient 
incompatible. 
The basis of the HPLC method developed and validated here is the extraction of PDMS 
from the acidified formulation and its separation on a reversed-phase column with a 
chloroform-acetonitrile solvent gradient. The detection and quantification is achieved 
using an Evaporative Light Scattering Detector. 
In the preliminary experiments, the operational parameters ofthe ELSD were examined 
to optimize the response, then this was compared to the response gained from a UV 
detector. The ELSD and UVD were set in series so that the same amount of sample 
passed through both detectors. Using paracetamol as the analyte, it was found that the 
reproducibility of the response of the ELSD was at least ten times worse than that of the 
UVD. It is clear that the principle of operation of the ELSD is more complex than that of 
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the UVD. Since the process involves nebulization and evaporation of the HPLC column 
effluent, there is a far greater chance of build-up of deposits that can interfere with the 
consistent operation of the detector. Regular cleaning of the nebulizer and drift tube was 
found to be essential to achieving acceptable reproducibility. 
It was also found that small variations in the nitrogen gas flow rate to the nebulizer were 
responsible for poor reproducibility of the ELSD. By continuous monitoring and manual 
adjustment of the nitrogen flow rate, the system precision of about 1.5% could be 
achieved. The poor control characteristics of the gas flow regulator appear to be a design 
fault of the particular model of the ELSD in use here. It is understood that later version 
have an improved gas flow regulator. The variation of gas flow can be circumvented, in 
principle, by the use of an internal standard in the HPLC assay procedure. In the present 
work, no suitable internal standard could be identified, so the validity of this approach 
could not be confirmed. Overall, with appropriate maintenance, the particular detector 
used here was found to a response precision of about 3% for successive detection of ten 
identical injections. In comparison, a UVD had a precision that was better than 0.3% for 
the same samples. In addition, for analytes such as paracetamol with high molar 
absorptivity, the ELSD was found to be one to two orders of magnitude less sensitive 
than the UVD. These characteristics confirm that the ELSD is not the first choice of 
detector for substances that have an appreciable UV absorption. 
An adequate separation of the PDMS extracted from the Mylanta Antacid Emulsion was 
attained with the solvent gradient. While the separation of low molecular weight (low 
viscosity of 200 cs) PDMS into its oligomers was achieved, the high molecular weight 
part (high viscosity) was only eluted as one complex peak. This can be explained on the 
basis of the larger relative difference in molecular weight for the oligomers of the low 
viscosity PDMS. Each oligomer is approximately 3% different in mass and capable of 
being resolved in the HPLC system. The high viscosity PDMS only has a 0.2% 
difference in mass between oligomers, this small difference is beyond the resolution 
capabilities of the present HPLC system. 
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Since no suitable internal standard could be found, the efficiency of the extraction 
procedure was studied. Three extractions were used for the preparation of the sample. It 
was found that complete extractions were often hampered by poor phase separation, but 
this difficulty was overcome by acidifying the sample with HCl as the first step before 
extraction. The acidified sample showed less tendency to emulsify and gave clear 
interfaces in the separation. 
In order to validate the method, a series of tests were performed, including the 
selectivity of the HPLC separation, the precision of the overall assay method, the 
efficiency of the recovery of PDMS, the stability of the sample solutions after 
reconstitution, the linearity and working range for the calibration curve and possibility 
of the loss of analyte by the membrane binding during the filtration. There are a variety 
of ways to validate selectivity, but the simplest test for chromatographic analysis is to 
demonstrate a lack of response at the relevant retention time in the chromatogram 
obtained with the blank placebo matrix. No peak was found at the same retention time 
ofthe PDMS peak, hence the matrix has no interference to the detection of PDMS. 
The recovery of PDMS following extraction from a PDMS standard solution was found 
to be 97.8 ± 2.5%. While this figure is not significantly different from 100%, and the 
general level of precision of the detection was 3%, this slight correction was applied to 
subsequent determinations of the PDMS content of Simethicone Emulsion used as raw 
material in the formulation. This assay gave the PDMS content as 27.3 ± 0.4%, which 
was lower than the value of 28.6% on the Certificate of Analysis provided by the 
manufacturer. The necessary liquid handling cell for FTIR was not available to carry out 
a comparison analysis using the USP method. No information was available upon which 
to make a judgement on the precision of the USP FTIR method for PDMS 
quantification. It is important to note that the USP method involves a single extraction 
step. In the current assay developed, experiments showed there was no significant 
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difference when 2, 3, or 4 extractions were performed. However, 3 extractions were 
used in the validated method to ensure that extraction was as complete as possible, and 
to assist the assay precision. 
The assay for the Simethicone content in the antacid formulation was based on the 
principle that known weights of Simethicone Emulsion (in the range of 50 to 150% of 
nominal content) were ~dded to 10 g of placebo matrix for construction of the so-called 
"Recovery Standard Curve". These "standards" were treated in the same manner as the 
formulation samples, so that the area of the PDMS peak was a representation of a known 
amount of Simethicone. Thus the assay delivered the result as the amount of 
Simethicone rather than the PDMS content. On the assumption that the efficiency of 
extraction was identical across all samples and standards, there was no need to make any 
adjustment for an incomplete extraction. 
In summary, a new HPLC method for determination of the content of Simethicone in 
Mylanta Antacid Suspension has been developed and validated. The method produced a 
mean Simethicone content of 36.8 ± 0.6 mg/1 0 mL, with a relative standard deviation of 
1.7% for three different batches of the formulation. At this stage, the HPLC assay was 
concerned with Mylanta Antacid Suspension only. It is anticipated that there would be 
little difficulty in extending the method to the analysis of other formulations containing 
Simethicone. 
The results from the HPLC assay were compared with those obtained using the USP 
FTIR method provided by the manufacturer. Agreement between the two sets of results 
ranged between 92 to 99%. It was found that the Simethicone content in Mylanta Antacid 
Suspension was consistently lower than that the label claim. 
Several different batches of Mylanta Antacid Suspension were analyzed for Simethicone 
content to check the stability of the Simethicone in the formulation under different storage 
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conditions. The test results were compared with those from the USP FTIR method, which 
were provided by the manufacturer. Mylanta Antacid Suspension stored at 5°C gave a 
higher Simethicone content than those stored at higher temperatures of 30 and 40°C. Also, 
the longer the storage time, the lower the Simethicone content. This indicated that there 
was an apparent degradation of the Simethicone content with storage at high temperatures. 
Chromatograms of the newest and oldest batches were compared and it was found that the 
chromatogram of the oldest batch showed a slight difference indicating a change in the 
nature of the PDMS after storage. The resolution of the chromatographic separation was 
insufficient to determine whether there was a substantial change in the nature of the 
PDMS after storage. If degradation of the polymer chains occurred, the shape of the 
PDMS peak would be expected to change in the HPLC analysis. That is based on the 
assumption that the broad shape of the peak is caused by the presence of different 
oligomers. The fact is that there is a significant loss of total PDMS content of the 
formulation upon storage, but only a barely perceptible change in the shape of the 
chromatogram, suggests that some of the polymer (the lower molecular weight chains) 
may be lost by evaporation. This idea would require a large number of PDMS samples of 
differing molecular weight distribution to be examined. 
An attempt was made to degrade the PDMS by sonicating the sample for up to 60 minutes 
using a sonication bath, but from the chromatogram, there was no effect observed. From 
the literature studies on the degradation of silicone polymers, it appears that severe 
conditions, such as temperatures greater than 150°C and strong alkaline reagents are 
necessary to cause the breakdown of the polymer. As an extension to this project, a fuller 
stabi1ity study could be undertaken to establish whether Simethicone degrades (or 
evaporates) under the effect of temperature and whether the presence of the alkaline 
components ofthe antacid formulation has any influence. 
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